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Aim of the Research: To compare the efficacy of Casein Phosphopeptide- 
Stabilised Amorphous Calcium Fluoride Phosphate (CPP-ACFP) 900 ppm (MI 
Paste Plus™) combined with fluoride toothpaste 1450 ppm F as a regimen with 
Functionalised tri-calcium phosphate (f-TCP) 950 ppm (Clinpro tooth crème™) 
and fluoride toothpaste 1450 ppm F, on de/remineralisation dental enamel in an 
in situ randomised, cross-over design study. 
 Materials and Methods: Sterilised bovine enamel slabs, intact and with 
subsurface caries-like lesions, were prepared and worn by healthy volunteers 
(n=14). The study had four arms, 21-day duration each.  Four pastes were 
tested (i) Placebo (0-ppm), (ii) 1450 ppm F, (iii) MI Paste Plus combined 
fluoride toothpaste 1450 ppm F, (iv) Clinpro tooth crème 950 ppm F. The 
pastes were randomly assigned and each subject crossed over to each paste 
after a seven-day washout period. Slabs were subjected to a five times/day 
cariogenic challenge (12% sucrose) with the subjects using one of the 
treatments. Volunteers dipped their appliances twice/day for 2 minutes, in a 
slurry of the toothpastes. For group 3, additionally, the appliance was dipped 
for 3 min in a slurry MI Paste Plus once/day immediately following the second 
exposure to the slurry of 1450 ppm F. Further de/remineralisation were 
assessed using Quantitative Light-Induced Fluorescence (QLF) and Surface 
Microhardness before and after the treatment period.  





(p< 0.05) in lesion volume (ΔQ) compared to the placebo. No statistically 
significant differences were found between the test groups. The Microhardness 
results for all test groups showed a significant increase (p<0.05) of enamel 
hardness compared with the placebo. No statistically significant differences 
were found between the test groups. 
Conclusion: The use of MI Paste Plus in combination with 1450 ppm F 
toothpaste did not show a greater reduction of enamel subsurface lesions or 
decreased demineralisation of sound enamel in comparison to 1450 ppm F 








TABLE OF CONTENTS 
 
ACKNOWLEDGEMENTS .............................................................................. i 
ABSTRACT ................................................................................................... ii 
TABLE OF CONTENTS ............................................................................... iv 
TABLE OF TABLES ................................................................................... viii 
TABLE OF FIGURES .................................................................................... x 
1.0 INTRODUCTION ................................................................................... 1 
2.0 LITERATURE REVIEW ......................................................................... 3 
2.1 Dental caries .................................................................................... 3 
2.1.1 Pathogenesis of dental caries ................................................. 3 
2.1.2 Demineralisation and Remineralisation ................................... 4 
2.1.3 Enamel caries ......................................................................... 6 
2.1.4 Role of saliva ........................................................................... 7 
2.2 Enamel Remineralisation Therapies ................................................. 8 
2.2.1 Fluoride ................................................................................... 9 
2.2.2 Casein Phosphopeptide-Amorphous Calcium Phosphate 
(CPP-ACP) ............................................................................ 18 
2.2.3 Functionalised tricalcium phosphate (f-TCP) ............................ 38 
2.3 Methods of study design used in caries research ........................... 42 
2.3.1 In vitro ................................................................................... 42 
2.3.2 In situ .................................................................................... 43 
2.3.3 In vivo ....................................................................................... 50 
2.4 Methods of mineral assessment ..................................................... 51 
2.4.1 Microhardness ....................................................................... 51 
2.4.2 Quantitative light-induced fluorescence (QLF) ...................... 53 
2.4.3 Transverse Microradiography (TMR) .................................... 55 
2.5 Research aims and hypotheses ..................................................... 56 





2.5.2 Objectives ............................................................................. 56 
2.5.3 Null hypotheses ..................................................................... 57 
3.0 MATERIALS AND METHODS ............................................................ 58 
3.1 Study Design .................................................................................. 58 
3.2 Ethical and regulatory aspects ....................................................... 59 
3.2.1 Training and calibration ......................................................... 59 
3.2.2 Sample size and power calculation ....................................... 60 
3.2.3 Recruitment and selection of participants ............................. 60 
3.2.4 Inclusion Criteria ................................................................... 61 
3.2.5 Exclusion criteria ................................................................... 61 
3.2.6 Subject withdrawal criteria .................................................... 62 
3.2.7 Subject replacement ............................................................. 62 
3.2.8 Investigational products ........................................................ 62 
3.3 Test methods used in de/remineralisation evaluation: .................... 64 
3.3.1 Quantitative Light-Induced Fluorescence (QLF) .................... 64 
3.3.2 Knoop Microhardness (KMH) ................................................ 70 
3.3.3 Experimental appliance ......................................................... 74 
3.4 Randomisation and blindness ........................................................ 75 
3.5 Study procedures ........................................................................... 76 
3.5.1 Informed consent .................................................................. 76 
3.5.2 Screening visit ....................................................................... 76 
3.6 Treatment Phases .......................................................................... 78 
3.6.1 Wash-in period ...................................................................... 78 
3.6.2 Acclimatisation period ........................................................... 78 
3.6.3 Plaque build-up period .......................................................... 78 
3.6.4 Investigational product use period ......................................... 79 
3.6.5 Day 21 ................................................................................... 79 
3.6.6 Washout ................................................................................ 79 
3.6.7 Follow up visit ........................................................................ 80 
3.7 Study regime .................................................................................. 80 
3.8 Flow Charts .................................................................................... 85 
3.8.1 Flow chart regime of the study arms using fluoride 1450 ppm 





3.8.2 Flow chart regime of the study arm using MI Paste Plus(10% 
w/v CPP-ACP, 900 ppm sodium fluoride) + fluoride toothpaste 
1450 ppm F (0.32% w/w sodium fluoride) as a regimen. ...... 86 
3.9 Compliance .................................................................................... 87 
4.0 RESULTS ............................................................................................ 88 
4.1 Quantitative Light-induced Fluorescence (QLF) Results ................ 88 
4.1.1 The mean fluorescence loss ΔF ............................................ 88 
4.1.2 ΔQ: Lesion volume ................................................................ 96 
4.1.3 Area of the White spot lesion .............................................. 104 
4.1.4 Summary of the results for all QLF three parameters 
(Remineralisation assessment) ........................................... 111 
4.2 Microhardness results .................................................................. 112 
4.2.1 Test of normality of Indentation length ................................ 112 
4.2.2 Difference in indentation length within the same group ....... 113 
4.2.3 Difference in Indent length between all groups ................... 114 
4.2.4 Intra-examiner reproducibility for indentation length ............ 117 
4.2.5 Summary of the Microhardness results (Demineralisation 
assessment) ........................................................................ 118 
5.0 DISCUSSION .................................................................................... 119 
5.1 In situ model ................................................................................. 120 
5.2 Study design ................................................................................. 120 
5.3 Sample size .................................................................................. 121 
5.4 Standardisation ............................................................................ 122 
5.5 Hard tissue substrates .................................................................. 123 
5.6 Artificial caries lesion .................................................................... 124 
5.7 Intra-oral appliance design ........................................................... 125 
5.8 Use of Quantitative Light-induced Fluorescence (QLF) ................ 126 
5.9 Use of Microhardness ................................................................... 127 
5.10 Remineralisation potential of the test products on artificial 
subsurface like lesions using QLF ................................................ 129 
5.10.1 Effect of CPP-ACPF + 1450 ppm NaF as a regimen........... 130 
5.10.2 The benefits of using CPP-ACFP as a regimen with fluoride 
over the use of fluoride products alone ............................... 130 
5.10.3 Comparison of remineralisation ability of CPP-ACFP and 





5.11 The ability of the test products to inhibit enamel demineralisation 
using microhardness .................................................................... 134 
5.12 Remineralising potential of f-TCP technologies ............................ 136 
5.13 Suggestion for future research ...................................................... 137 
5.14 Null hypotheses outcome .............................................................. 138 
6.0 CONCLUSION ..................................................................................... 140 
REFERENCES .......................................................................................... 141 
APPENDICES ............................................................................................ 156 
Appendix 1: Ethical approval from the Dental Research Ethics Committee 
of University of Leeds. .................................................................. 156 
Appendix 2: Advertisement poster of the study ..................................... 157 
Appendix 3: Randomisation .................................................................. 158 
Appendix 4: Patient information sheet .................................................. 162 
Appendix 5: Consent form .................................................................... 167 
Appendix 6: Case record form (CRF). ................................................... 168 
Appendix 7: Dipping diary and instruction sheet for non- regimen groups.
 …………………………………………………………………………185 









TABLE OF TABLES 
Table 2-1: Main variations between human and bovine dental tissues 49 
Table 2-2: Main QLF parameters that are used for caries research ...... 53 
Table 4-1: One-way ANOVA between groups for ΔF values at baseline.
 ............................................................................................................. 89 
Table 4-2: Mean values of ΔF at baseline and after treatment for all 
groups. ................................................................................................ 90 
Table 4-3: Paired sampled T-Test results for ΔF values at baseline and 
after treatment. ................................................................................... 91 
Table 4-4: Descriptive statistics for the difference in ΔF at baseline and 
after treatment for all groups. ........................................................... 92 
Table 4-5: One-way ANOVA between groups for the difference in ΔF 
from baseline. .................................................................................... 94 
Table 4-6: Multiple comparisons of the difference in ΔF at baseline and 
after treatment between all test groups and control. ..................... 95 
Table 4-7: The mean values of ΔQ at baseline and after treatment for all 
groups. ................................................................................................ 97 
Table 4-8: Paired sampled T-Test results for ΔQ values at baseline and 
after treatment. ................................................................................... 98 
Table 4-9: Descriptive statistics for the difference in ΔQ from baseline 
for all groups. ................................................................................... 100 
Table 4-10: One-way ANOVA between groups for the difference in ΔQ 
at baseline and after treatment. ...................................................... 101 
Table 4-11: Multiple comparisons of the difference in ΔQ at baseline 
and after treatment between all test groups and control. ............ 102 
Table 4-12: The mean values of lesion area at baseline and after 
treatment for all groups. .................................................................. 104 
Table 4-13: Paired sampled T-test results for the lesion area values at 
baseline and after treatment for all groups. .................................. 106 
Table 4-14: Descriptive statistics for the difference in the lesion area at 
baseline and after treatment for all groups. .................................. 107 
Table 4-15: One-way ANOVA between groups for lesion area values 
difference .......................................................................................... 109 
Table 4-16: Multiple comparisons of the difference in area at baseline 





Table 4-17: Tests of Normality (indent length - KMH). .......................... 112 
Table 4-18: Change from baseline (indent length - KMH). .................... 113 
Table 4-19: Comparison between different formulations of toothpastes 
on the hardness of enamel using the length of the indent (Mean 







TABLE OF FIGURES 
Figure 2-1  The caries balance concept (Featherstone, 2008) ................. 5 
Figure 2-2 Upper removable acrylic appliance ........................................ 47 
Figure 2-3: Lower removable appliance with two buccal acrylic flanges
 ............................................................................................................. 47 
Figure 3-1 Diamond wire saw cutting machine (Well® Walter EBNER, 
CH-2400 Le Loche). ........................................................................... 65 
Figure 3-2 QLF machine, the SLR camera attached to the stand with 
standardised distance from the enamel slab. ................................. 67 
Figure 3-3: QLF image taken with the blue light shows the 
demineralised lesion in the centre of the enamel slab as well as a 
patch drawn around the lesion with the border in sound enamel. 68 
Figure 3-4:  The computer-aided Duramin Indenter Machine (Struers 
A/S, DK 26-10, Denmark). .................................................................. 71 
Figure 3-5: Microscopic image of diamond shape indentation on the 
enamel surface of the enamel at baseline. ...................................... 72 
Figure 3-6: Lower removable appliance with two buccal acrylic flanges.
 ............................................................................................................. 74 
Figure 4-1: Boxplot for the distribution of the ΔF values at baseline, 
demonstrating the upper and lower values, Standard deviation 
(SD) and the median value of the data. ............................................ 89 
Figure 4-2: ΔF mean values at baseline and after treatment for all 
groups. ................................................................................................ 90 
Figure 4-3:  The mean difference in ΔF in the four groups. ................... 92 
Figure 4-4: The % change in ΔF values from baseline for all groups. .. 93 
Figure 4-5: ΔQ mean values at baseline and endpoint for all groups. .. 97 
Figure 4-6: Means of the difference in ΔQ at baseline and after 
treatment of all groups. ..................................................................... 99 
Figure 4-7: The % Q values for all groups. ............................................ 101 
Figure 4-8: Lesion area at baseline and after treatment for all groups.
 ........................................................................................................... 105 
Figure 4-9: Means of the difference in the lesion area. ........................ 107 





Figure 4-11:  indent length(µm) baseline and after (indent length 
created by Knoop microhardness indenter (KMH). ...................... 114 
Figure 4-12: The effect of different formulations of toothpastes on 
enamel hardness (indent length created by indenter of MH) after 
cariogenic challenge. ...................................................................... 115 







Dental caries can be defined as “a transmissible bacterial disease process 
caused by acids from bacterial metabolism diffusing into enamel and dentine 
and dissolving the mineral” (Featherstone, 2008). Despite massive prevention 
efforts, dental caries is still the most common disease in the United Kingdom 
and globally. 
More conservative approaches are now advocated secondary to a better 
understanding of caries and oral environment. It is now well understood that 
caries is a dynamic process that results from the imbalance between 
demineralisation and remineralisation (Featherstone, 2008). 
In recent years, several preventive agents have been introduced in conjunction 
with fluoride dentifrices for daily home use and deemed to be effective products 
to inhibit demineralisation and enhance remineralisation of the enamel. Two 
calcium and phosphate products have been introduced and claimed to be more 
effective than the routine use of fluoridated toothpaste; Casein phosphopeptide 
-amorphous calcium phosphate (CPP-ACP) and functionalised tricalcium 
phosphate (f-TCP) technologies.    
The anti-caries effect of CPP-ACP has been reported in several studies 
(Reynolds, 2009; Reynolds, 2008). The anti-caries effect is believed to be due to 
the formation of stabilised amorphous calcium phosphate in the tooth surface 




The synergic effect of CPP-ACP and fluoride has also been investigated in the 
literature. Several studies have reported a positive synergic effect on inhibiting 
demineralisation and enhancing remineralisation of the enamel (Mendes et al., 
2018; Altenburger et al., 2010; Reynolds et al., 2008). However, the benefits of 
using it as a regimen with fluoride over the use of fluoride products alone are 
investigated by a limited number of studies and is a matter of scholarly debate. 
More recent, f-TCP technology has been developed by 3M ESPE Inc and 
claimed to be able to maintain high levels of calcium, phosphate and fluoride in 
the oral environment (Amaechi, 2015; Jo et al., 2014). This technology is now 
commercially available as Clinpro toothpaste™ with (5000 ppm NaF), Clinpro 
tooth crème™ with (950 ppm NaF) and fluoride varnish with (22600 ppm NaF).  
However, very limited clinical trials have investigated its remineralisation effect. 
Therefore, the aim of this in situ study was to compare the efficacy of MI Paste 
Plus combined with fluoride toothpaste 1450 ppm F (0.32% w/w sodium 
fluoride) as a regimen with Clinpro tooth crème and fluoride toothpaste 1450 
ppm F (0.32% w/w sodium fluoride), on remineralisation of the enamel 








2.0 LITERATURE REVIEW 
2.1 Dental caries 
Dental caries has been discussed extensively in the literature. It is considered 
one of the most common causes of mineral loss. It has been defined as “a 
transmissible bacterial disease process caused by acids from bacterial 
metabolism diffusing into enamel and dentine and dissolving the mineral” 
(Featherstone, 2008). 
Despite massive efforts in the prevention of dental caries, it is still one of the 
main issues in the United Kingdom and globally. Data obtained from the latest 
Child Dental Health Survey in England, Wales and Northern Ireland showed 
that in 2013, approximately half of 15-year-olds and almost one-third of 12-
year-olds suffered from noticeable dental caries in their successor's teeth. In 
addition, nearly 33% of 5-year olds and about a half of 8-year olds had visible 
dental caries in their primary teeth. Although the survey stated that there was a 
reduction in the caries prevalence compared with the Child Dental Survey in 
2003, this disease remains a significant problem in the United Kingdom (Health 
& Social Care Information Centre, 2015). 
2.1.1 Pathogenesis of dental caries 
The dynamic process of dental disease is now clear and well described in the 
literature. The dental caries process is affected by many pathological and 




carbohydrate, saliva flow and the use of remineralisation products 
(Featherstone, 2008; Featherstone, 2004). 
The bacteria responsible for dental caries (Streptococcus mutans, 
Streptococcus sobrinus and Lactobacillus Spp) mainly interact with fermentable 
substances and produce organic acids. The acids formed include lactic, acetic, 
formic and propionic, which then can penetrate and diffuse through enamel and 
dentine into underlying structures and start to dissolve acid-soluble minerals. 
This process, over time, can lead to dental cavitation (Featherstone, 2008). 
 
2.1.2 Demineralisation and Remineralisation 
As described above, dental caries is a dynamic process affected by 
pathological and protective factors, occurring over a period of time. In the 
mouth, as long as there are acid-producing bacteria, fermentable substances 
and saliva, cycles of demineralisation and remineralisation will continue to 
affect the tooth structure (Featherstone, 2008). Remineralisation can occur if 
there is an imbalance towards the protective factors. However, any shift in the 
balance towards the pathological factors will lead to demineralisation  
(Figure 2-1). 
Therefore, demineralisation can be defined as “the loss of calcified material 
from the structure of the tooth. This chemical process can be biofilm mediated 
(i.e. caries) or chemically mediated (i.e. erosion) from exogenous or 





Conversely, remineralisation is “the net gain of calcified material within the 
tooth structure, replacing that which was previously lost through 
demineralisation”(Fontana et al., 2010). 
 





2.1.3 Enamel caries 
Darling (1956) histologically classified the enamel lesion under a polarised light 
microscope into four different zones to demonstrate the different phases of 
demineralisation and remineralisation: 
1- The translucent zone: This is defined as at the deepest part of the enamel 
lesion with a mineral loss of about 1.2% and is more porous compared to the 
normal enamel structure (Hallsworth et al., 1973). 
2- The dark zone: This is defined as the area located next to the translucent 
zone and is characterised by a mineral loss of approximately 5–10%  
(Hallsworth et al., 1973).The chemical analysis of the material from this zone 
revealed a tooth structure closer to the apatite (Robinson et al., 2000). 
3- The body of the lesion: This accounts for the highest percentage of mineral 
loss with up to around 30% of mineral loss (Hallsworth et al., 1973).  Robinson 
et al. (2000) stated that fewer soluble materials were found in this zone 
following chemical analysis of mineral loss. 
4- The surface zone: Around 1-10% mineral loss is seen in this zone with a 





2.1.4 Role of saliva 
Saliva is a diluted liquid comprising more than 99% water and is produced from 
the major salivary glands (parotid, submandibular and sublingual) and several 
minor salivary glands with a neutral pH level between 6 to 7 (Garcia-Godoy and 
Hicks, 2008). 
The average salivary flow has considerable individual variation. However, the 
minimum unstimulated and stimulated salivary flow rates have been discussed 
in the literature as being more than (0.1 mL/min and 0.2 mL/min) respectively. 
Reduction in the quantity or quality of saliva can lead to dental caries (García-
Godoy and Hicks, 2008). 
Saliva plays a vital role in maintaining optimum oral health. Its functions can be 
classified into the following  main rules (García-Godoy and Hicks, 2008): 
 Lubrication of the oral environment and protection from damage to the 
soft tissue during mastication 
 The saliva acid’s buffering capacity and food clearance  
 Preservation of tooth integrity 
 Antibacterial ability against microorganisms due to the presence of 
proteins, mucins immunoglobulins, enzymes and nitrogenous products, 
such as urea and ammonia 
 It has a role in helping with taste and digestion  





Many clinical studies have investigated the role of saliva in the prevention of 
dental caries. In a review that included seven clinical studies, the effect of 
stimulated saliva using sugar-free chewing gum was investigated. The result 
showed a significant reduction in caries’ incidence due to the increase in 
salivary flow rather than the chewing gum (Kalin, 2011). 
It has been concluded that saliva is considered the key biological factor to 
maintain oral health. This is not only for the prevention of dental caries but also 
the prevention of other diseases like erosion (Afonso et al., 2012). 
2.2 Enamel Remineralisation Therapies 
Chole et al. (2016) described the ideal requirements for enamel 
remineralisation therapies as follows: remineralisation therapy should be able 
to diffuse or deliver calcium and phosphate into the enamel subsurface. At the 
same time, it should not deliver excess calcium that could interfere with the 
fluoride. It should also be able to function in an acidic environment. Moreover, it 
should encourage the saliva function and be able to work in xerostomic oral 
conditions.  
In this part, different enamel remineralisation agents will be discussed with the 
main focus on the use of fluoride, Casein Phosphopeptide-Amorphous Calcium 






2.2.1 Fluoride  
Fluoride plays an important role in the prevention of enamel demineralisation 
and in enhancing enamel remineralisation. The anti-cariogenic properties of 
fluoride have been one of dentistry’s great discoveries (Fejerskov, 2004). The 
evidence behind the anti-caries ability is well-established. Many studies have 
shown that regular use of fluoridated toothpaste has a major impact on caries 
reduction (Marinho et al., 2016). 
2.2.1.1 Mechanism of action of fluoride 
Several mechanisms have been discussed in the literature to explain how 
fluoride’s mechanism act, which includes the systemic and local effect on teeth. 
The systemic effect is during tooth formation and topically after the eruption of 
the teeth, however, numerous systematic reviews and studies have shown that 
the principle action of fluoride is through its topical rather than its systemic 
effect (Marinho et al., 2016). 
The proposed mechanisms of action for fluoride systematically (pre-eruptive 
mechanism)  (Cate and Cate, 1999; Featherstone, 1999) are: 
 (i) It has an effect during crown formation by creating shallow pits and fissures, 
which affects the crown. 
 (ii)  It also plays an important role during tooth formation by stabilising the 
enamel crystals. 
Topically, fluoride works directly on the surface of erupted teeth (post-eruptive 




(i) The first is that it inhibits demineralisation when in solution. Fluoride that 
comes from local sources like water and other fluoride products can impede 
enamel crystal dissolution when fluoride is present in a solution at a low level.  
(ii) Secondly, it enhances remineralisation when in solution by forming 
fluorapatite. Fluoride from topical sources, when present in solution, improves 
remineralisation by attracting calcium and phosphate ions, thereby forming a 
new layer which is fluorapatite-like. Fluorapatite is more resistant at a lower pH 
than hydroxyapatite. 
(iii) The third way is by inhibiting plaque bacteria. It has been shown that 







2.2.1.2 Fluoride products and delivery systems 
There are several ways to deliver fluoride supplements including fluoride 
dentifrices, varnishes, gels and mouth rinses. Fluoride can also be 
supplemented via systemic methods like water fluoridation, milk fluoridation 
and tablets.  
 
2.2.1.2 a Fluoride toothpaste 
The introduction of fluoridated toothpaste has been associated with the 
increased reduction of dental caries over the last four decades (European 
Academy of Paediatric Dentistry, 2009). A Cochrane review, published by 
Marinho et al. (2016), which included 42300 children, concluded that brushing 
with fluoridated toothpastes significantly reduces dental caries compared to 
non-fluoridated toothpastes. The authors also concluded that the anti-caries 
effectiveness increases with the frequency of tooth brushing, supervised 
brushing and increased DMFT baseline.  
The effectiveness of different fluoride concentrations for toothpastes has also 
been extensively investigated. A Cochrane review of 75 studies, to investigate 
the anti-caries efficacy of different concentrations of fluoridated toothpastes, 
concluded that the caries reduction efficacy is dose-dependent. It also found 
that the anti-caries effect was only significant for 1000 ppm and above (Walsh 
et al., 2010). These results are in line with the current guidelines for the use of 





2.2.1.2 b Fluoride rinses  
In addition to the use of toothpastes, fluoridated mouth rinses can be 
considered for patients at high risk of caries (Toolkit, 2017; European Academy 
of Paediatric Dentistry, 2009). Such mouth rinses are commercially available as 
daily (225 ppm F) and weekly (900 ppm F). The main advantages of using 
these mouth rinses are the short contact time and low fluoride concentration. 
However, patient compliance is crucial to increase its efficiency and avoid 
fluoride toxicity.  
The anti-caries effectiveness of fluoridated mouth rinses has been investigated 
in the literature. A recent Cochrane review, which included 35 clinical trials with 
more than 15800 patients, found a significant caries reduction of 27% when 
compared with placebo mouth rinses (Marinho et al., 2015). 
 
2.2.1.2 c Fluoride varnishes 
The effectiveness of fluoride varnish has been shown in several systematic 
reviews. A recent Cochrane review included 22 trials with approximately 12000 
participants. It found that fluoride varnish significantly reduces dental caries in 
primary and permanent teeth (37% and 43%) respectively when compared with 
no treatment (Marinho et al., 2013). 
Fluoride varnishes offer several advantages including being available in 
different flavours, and they do not have a bitter taste like acidulated phosphate 
fluoride gel. There are also easy and quick to apply and require minimal clinical 




saliva, which maximises the effect. Moreover, fluoride varnishes can be applied 
by dental nurses under a dentist’s prescription, provided that the nurses have 
undertaken the required training (DOH Toolkit, 2017). 
Fluoride varnishes are available in different types for example Duraphat™ with 
2.2% NaF, Fluor Protector™ with 7% ammonium fluoride and Bifluoride™ with 
5.63 % NaF. The current recommendation for the use of fluoride varnish is to 
apply the varnish (2.2% NaF) twice a year for all children aged three years and 
above (DOH Toolkit, 2017). 
  
2.2.1.2 d Fluoride gel 
Fluoride gels with low fluoride concentration can be used as self-application 
home products. They are also available for professional use at high 
concentrations (1.23%). Fluoride gel can be obtained from different fluoride 
formulations including acidulated phosphate fluoride, sodium fluoride and 
stannous fluoride.  
In a recent Cochrane review that investigated the effectiveness and safety of 
fluoride gel, twenty-eight studies (9000 children) were combined. The results 
showed 27% caries reduction with fluoridated gel compare with placebos. It 
also found studies that reported unwanted adverse effect s were mainly 
associated with swallowing the gel (Marinho et al., 2015). Due to toxicity 





2.2.1.3 Fluoride toxicity 
The optimum daily intake of fluoride is between 0.05 -0.07 mg/kg. Excess 
consumption of fluoride may lead to fluoride toxicity. This can be classified as 
chronic or acute based on the duration and concentration of the consumed 
fluoride.  
2.2.1.3.1 Acute fluoride toxicity 
This is defined as the ingestion of a large dose of fluoride over a short period. 
Several signs and symptoms can be associated with acute fluoride toxicity. The 
severity of symptoms is dependent on the amount of ingested fluoride.  
Signs and symptoms of acute fluoride toxicity (Shulman and Wells, 1997): 
 “Nausea, vomiting 
 Abdominal pain 
 increased salivation 
 Generalized weakness, muscle spasm and pain 
 Reduced plasma calcium level, increased plasma potassium level 
 Weak pulse, low blood pressure  
 Cardiac arrhythmia  
 Cardiac failure 
 Respiratory system failure  
 Coma and death” 
A lethal fluoride dose can be defined as the ingested dose that would be lethal 
if not treated promptly. This has been estimated at between 32 and 64 mg/kg 




However, the toxic dose definition is, “the minimum dose that could cause 
serious life-threatening systemic signs and symptoms and that should trigger 
immediate therapeutic intervention and hospitalisation”, which was estimated to 
be 5.0 mg/kg NaF (Whitford, 1989).    
Acute toxicity should be managed immediately by inducing vomiting to reduce 
the fluoride absorption. Acute fluoride toxicity is a life-threatening condition; 
therefore, the patient needs to be transported to the emergency department as 





2.2.1.3.2 Chronic fluoride toxicity  
This is defined as the ingestion of an excess amount of fluoride level over a 
prolonged period. Chronic toxicity depends on many factors, including fluoride 
level in the body, the stage of tooth development, the fluoride dose and the 
length of exposure to fluoride. Furthermore, renal function and interaction with 
other materials contribute to the toxicity level (DenBesten and Li, 2011; Ullah et 
al., 2017). Chronic toxicity from fluoride can have a wide range of effects 




The ingestion of excess fluoride during tooth formation can result in dental 
fluorosis, one of the most common problems associated with chronic toxicity 
from fluoride. Furthermore, it is an early sign of chronic fluoride toxicity. In the 
United States, according to a National Health and Nutrition Examination 
Survey, the dental fluorosis prevalence has increased in children aged 15-17-
year-old. In the 1999-2004 study, 40.6% of children aged 15-17-year-old had 
dental fluorosis compared with the lower prevalence (22.6%) recorded in an 








Skeletal fluorosis is one of the complications that result from fluoride toxicity. It 
is defined as an increased deposition of fluoride within the bone. Many 
symptoms can be seen with skeletal fluorosis, including joint rigidity, bone pain 
and difficulties with movement. Radiographic signs may act as osteosclerosis 
and calcification of ligaments (Ullah et al., 2017). 
 
Renal effects  
 
Approximately 60% of fluoride excretion occurs in the kidneys. The excess 
consumption of fluoride, over recommended doses, may cause renal structural 
changes due to fluoride toxicity. These can include swelling, degeneration of 
tubular epithelium, fibrosis, atrophy of glomeruli and tubular necrosis (Ullah et 
al., 2017). 
 
Gastrointestinal tract (GIT) effects 
 
In the gastrointestinal tract (GIT) system, high fluoride can irritate the gastric 
mucosa. This irritation is caused by the formation of hydrofluoric acid that 







2.2.2 Casein Phosphopeptide-Amorphous Calcium Phosphate 
(CPP-ACP) 
The clinical application and remineralisation benefits of using calcium and 
phosphate were limited and ineffective in the past. This is secondary to the low 
solubility of these ions, especially with fluoride ions’ presence. The low 
solubility of the ions complicates their localisation effectively at the tooth 
surface. In addition, acid is usually required to make these ions more soluble 
and able to diffuse into enamel subsurface lesions. Thus, the application of 
insoluble calcium phosphate is not easy (Reynolds, 2009). 
The intrinsic insolubility of soluble calcium and phosphate ions, especially the 
calcium fluorophosphate, makes the use of these ions very limited, only at low 
concentration levels. Moreover, the ability of soluble calcium and phosphate 
ions to penetrate the subsurface enamel is reduced as they do not effectively 
bind to dental plaque (Reynolds, 2009). 
To overcome the limitations of the bioavailability of calcium and phosphate ions 
and to enhance remineralisation, many calcium phosphate-based technologies 
have been introduced and discussed in the literature. One such system 
involves using CPP-ACP. In this technology, an increased level of calcium, 
phosphate and fluoride are maintained and stabilised, at the tooth structure by 
casein phosphopeptide (CPP). Casein phosphopeptide (CPP) binds these ions 
to pellicle and plaque. The bioavailability of the stabilised ions is claimed to 
have been improved, enabling the ions to penetrate and diffuse into the enamel 




The anti-caries effect of dairy products has been shown in numerous in vitro 
and in situ animal and human models. The anticariogenic ability mainly comes 
from casein, calcium and phosphate. In a rat caries model, Reynolds and del 
Rio (1984) showed that the addition of soluble sodium caseinate, at 2%, to 
drinking water, reduced caries’ activity in rats. In addition, Reynolds (1987) 
investigated the enamel demineralisation ability of sodium caseinate, alpha s1 
tr-casein, and tryptic digest of alpha s1- casein using a modified human in situ 
caries model. This study concluded that using 2% sodium caseinate prevented 
the enamel demineralisation caused by the sugar challenge used in the study. 
It also showed that consumption of alpha s1- casein did not affect the proteins’ 
anticariogenicity. In addition, the tryptic peptide of alpha s1- casein was found 
to be incorporated in the inter-enamel plaque, with high levels of calcium and 
phosphate in the plaque. 
It has been shown that caseinate’s anticariogenic activity is derived from the 
tryptic peptides that were the calcium-phosphate-stabilising casein 
phosphopeptides (Reynolds, 1998). CPP contains the group sequence of  -
Ser(P)-Ser(P)-Ser(P)-Glu-Glu-, which has the notable capability to stabilise 
ACP (Reynolds, 1997).  
CPP-ACP is commercially available in different forms. The most common are 
topical crème; Tooth mousse ™ (TM; GC Crop, Tokyo, Japan) and MI Paste 
Plus™ (GC MI Paste Plus; GC Crop, Tokyo, Japan) which contains 900 ppm 
fluoride in addition to CPP-ACP. CPP-ACP is less commonly found as chewing 





2.2.2.1  CPP-ACP mechanism of action  
CPP-ACP works effectively to stabilise and localise ACP in dental plaque and 
tooth surfaces. This function maintains a state of super-saturation, which 
inhibits demineralisation and enhances remineralisation of the enamel 
(Reynolds, 2008). 
The ability of (CPP) to inhibit plaque formation has been recorded in the 
literature. Guggenheim et al. (1999) showed that S. sobrinus numbers are 
significantly reduced in rats, secondary to the consumption of a diet containing 
casein or CPP.  Casein has also been shown to have the ability to inhibit 
adherence of S. mutans to a tooth’s surface (Reynolds, 1987). 
 
2.2.2.2 CPP-ACP Effect on Demineralisation 
As discussed earlier, CPP can localise ACP in dental plaque as well as on the 
tooth surface. This will help to buffer the available calcium and phosphate and 
maintain a state of supersaturation, which inhibits demineralisation and 
encourages remineralisation (Reynolds, 1998). Several in vitro and in situ 
studies have been conducted to evaluate the effect of CPP-ACP to prevent 
enamel and dentine demineralisation. 
Reynolds, (1987) conducted a 10 day in situ study using microradiography and 
microhardness tests to assess the ability of casein agents in preventing sub-
surface enamel demineralisation and incorporation into the plaque. The study 
concluded that inhibition of enamel demineralisation was seen by a twice-daily 
application of sodium caseinate 2%, oxt1-casein, or TD-casein solution (pH 




Moreover, Yamaguchi et al. (2006) conducted an in vitro study to investigate 
the effect of CPP-ACP on demineralisation by using field emission-scanning 
electron microscopy. In this experiment, the morphological characteristics of 
enamel and dentine were examined and evaluated over a period of 28 days. It 
was noted that the specimens treated in CPP-ACP prior to the acid challenge 
showed relatively slight changes in the tooth surface. 
Furthermore, Yamaguchi et al. (2007) evaluated the effect of CPP-ACP on 
inhibiting the dentine demineralisation. They used the ultrasound technique as 
an indicator for mineral loss in an in vitro study. No significant difference in the 
sonic velocity was found with the slabs of CPP-ACP paste used for 10 minutes 
before the acid challenge. They concluded that CPP-ACP has the ability to 
inhibit dentine demineralisation. 
In addition, the effect of using CPP-ACP paste on demineralisation and 
remineralisation were evaluated in vitro by using Fourier infrared spectroscopy. 
In this experiment, forty sound human dentine slabs were randomly allocated 
into four groups. To evaluate the effect of CPP-ACP on dentine 
demineralisation, Group A was treated with Tooth Mousse™ (CPP-ACP), 
whereas no treatment was applied to Group B. Both groups A and B were 
subjected to an acid challenge for seven days before being analysed. Groups C 
and D were used to assess the ability of Tooth Mousse to enhance 
remineralisation. Both groups C and D were subjected to seven days 
demineralisation challenge with no treatment applied prior to the challenge. 
Group C then was treated with Tooth Mousse™ while Group D received no 




before the analysis. The result indicated that the application of Tooth Mousse™ 
on the dentine surface inhibited demineralisation and enhanced 
remineralisation of the dentine surface in comparison to groups that received 
no agent (Rahiotis and Vougiouklakis, 2007). 
In contrast to above studies, Pulido et al. (2008) reported that Tooth Mousse 
Paste™ had no effect on lowering enamel demineralisation in vitro. The 
researchers studied the effect of Tooth Mousse Paste™ on preventing enamel 
demineralisation using Polarized-Light-Microscopy (PLM). In this study, enamel 
specimens were randomly assigned into four groups (n=21): Artificial saliva as 
a control group, 5000 ppm NaF, Tooth Mousse Paste™, 1100 ppm NaF and a 
combination of 1100 ppm NaF and Tooth Mousse Paste™. The duration of pH 
cycling of this study was six days at 20c°. Enamel slabs were exposed to two 
acid challenges a day. The agents were applied twice a day for two minutes 
and washed immediately after application. The result showed that minimal 
changes in lesion size and depth were noted in the 5000 ppm NaF compared 
with other groups. In the study, the application time was short, and products 
were washed out immediately after application. In addition, the samples were 
cycled for six days only. In most studies, the normal cycling protocol ranges 





2.2.2.3 CPP-ACP Effect on demineralisation around Orthodontic 
brackets 
Enamel demineralisation and development of white spot lesion are considered 
common side effects of orthodontic treatment (Benson et al., 2013). The effects 
of using topical treatment with calcium phosphate technologies and white spot 
lesion have been widely investigated in the literature.  
The effect of using MI Paste Plus ™ CPP-ACPF (900 ppm F) to prevent 
enamel decalcification around orthodontic brackets has also been studied. 
Robertson et al. (2011) carried out a double-blind, randomised clinical trial to 
evaluate the effectiveness of using MI Paste Plus ™ to inhibit enamel 
demineralisation in orthodontic patients. Fifty participants were randomly 
assigned into two groups: placebo (n=24) and treatment group (n=26). 
Participants were asked to use the pastes daily for 12 weeks, and the analysis 
was carried out using the enamel decalcification index (EDI) scores and the 
international caries detection and assessment system (ICDAS). It was found 
that the EDI score declined by 53.5% with the MI Paste Plus™ group but 
increased by 91% in the placebo group. The ICDAS results were in line with 
EDI scores. However, one of the limitations of this study was the use of 
subjective assessment systems, which can vary between examiners. 
Uysal et al. (2010) used in vitro and in vivo models to compare the ability of 
CPP-ACP and a fluoride agent to inhibit enamel demineralisation around 
orthodontic brackets. In the in vivo experiment, orthodontic brackets were 
bonded for 60 days on first premolars that were scheduled for orthodontic 
extraction. The participants (n=21) were randomly allocated into three groups: 




After 60 days, sixty-one teeth were extracted, and brackets were removed. 
Using cross-sectional microhardness, the efficacy of the test products on 
demineralisation was assessed in vivo. 
For the in vitro experiments, sixty extracted premolars were bonded and 
randomly divided into the same groups, as per the in vivo study. Teeth from 
treatment groups received a coat of prepared solution (0.5 mL) before the 
treatment in cycling solutions, while the control group received no agent before 
immersion in demineralisation and remineralisation solutions. Specimens 
underwent a pH cycling of 14 days. The findings of both experiments revealed 
that both agents have a definite benefit in lowering enamel demineralisation 
around orthodontic brackets compared with the control group. However, no 
statistically significant difference was detected between CPP-ACP and fluoride 
containing gels agents on minimising enamel demineralisation.  
Bröchner et al. (2011) carried out a randomised, single-blind, controlled trial to 
study the effect of applying CPP-ACP paste to white spot lesions, over the use 
of standard fluoride. Sixty subjects, who had visible white spot lesions, were 
randomly allocated into two groups. The intervention group (n=22) was asked 
to apply Tooth Mousse™ once a day in addition to the standard toothpaste 
brushing. The control group (n=28) was advised to brush normally twice a day 
with a standard toothpaste 1100 ppm F. After 28 days of application; the 
lesions were evaluated using quantitative light-induced fluorescence (QLF). It 
was found that the area of the lesions and the fluorescence were significantly 
reduced for both groups compared with the baseline readings. No statistically 




Furthermore, a recent evidence-based review was conducted to evaluate the 
effectiveness of CPP-ACP and CPP-ACPF to prevent enamel demineralisation 
and in enhancing enamel remineralisation on white spot lesions. It concluded 
that there is a tendency toward the benefit of using CPP-ACP to enhance 
enamel remineralisation for orthodontic patients. However, the quality of 





2.2.2.4 CPP-ACP Effect on Remineralisation  
The ability of CPP-ACP to enhance enamel remineralisation has been widely 
investigated using different study models. As discussed previously, CPP-ACP 
has a significant effect on increasing the level of calcium and phosphate in 
plaque, which enhances enamel remineralisation and inhibits plaque formation 
(Reynolds, 2009). 
 
In vitro studies 
Various in vitro studies have used different protocols to assess the ability of 
CPP-ACP products to enhance enamel remineralisation. Zhang et al. (2011) 
compared the remineralisation ability of CPP-ACP paste to 500 ppm NaF 
solution in an in vitro study. A total of ninety enamel slabs from primary teeth 
with enamel subsurface like lesions were randomly allocated into three groups. 
Group 1had deionised water as a negative control, Group2 used 500 ppm NaF 
solution as a positive control and Group 3 was 10% CPP-ACP paste. 
Remineralising agents were applied twice a day for thirty days. The enamel 
slabs were assessed at baseline before demineralisation and after thirty days 
of pH cycling, using surface a microhardness test. The study found a significant 
increase for the surface microhardness in the CPP-ACP group compared with 
others and concluded that CPP-ACP paste can potentially be used for the 
management of early childhood caries in primary teeth. These findings were in 
line with another in vitro study published by Zhou et al. in  2014. 
Moreover, the remineralising efficacy of CPP-ACPF (MI Paste™) pastes after 




microscopy and microradiography. Gopalakrishnan et al. (2017) used a 10-day 
pH cycling in vitro model to assess the remineralising ability of CPP-ACPF and 
the benefit of using fluoridated toothpaste (1000 ppm F) prior to the application 
of the CPP-ACPF paste. The results showed that the short application of CPP-
ACPF significantly remineralised the artificial enamel subsurface-like lesions. 
However no extra benefit was found in using fluoridated toothpastes prior to the 
CPP-ACPF application.  
In contrast with previous findings, Vyavhare et al. (2015) conducted an in vitro 
study to assess whether CPP-ACP can be used as an alternative to fluoridated 
toothpaste. Enamel subsurface lesions were created on extracted flat labial 
surfaces of extracted human incisor teeth. Enamel slabs were treated with four 
different agents: (i) Nano-hydroxyapatite (10%), (ii) CPP-ACP (10%), (iii) NaF 
(1000 ppm) and (iv) deionized water. The enamel slabs were assessed at 
baseline, after demineralisation and after 3, 6, 9 and 12 days of in vitro pH 
cycling using surface microhardness. In their results, the authors reported that 
the percentage surface microhardness recovery (%SMHR) was significantly 
higher in groups (i) and (iii) and concluded that CPP-ACP is not an effective 





In situ studies  
Numerous in situ studies have been carried out to investigate the 
remineralisation efficacy of CPP-ACP agents.  
Shen et al. (2011) conducted a 10-day double-blind, randomised, controlled 
cross-over in situ study to compare the remineralisation ability of different 
dental agents with added calcium and phosphate. In their study, enamel 
subsurface-like lesions were created on selected sound extracted human third 
molars. Enamel slabs were secured by sticky wax into upper removable 
appliances worn by five volunteers. Participants were instructed to rinse four 
times daily for 60 seconds using slurry of the assigned product. Volunteers 
were crossed over six products (i) placebo, (ii) 1000 ppm F, (iii) 5000 ppm F, 
(iv) Tooth Mousse™ (TM), (v) MI Paste™ (TMP) and (vi) Clinpro crème with 
950 ppm F, with a wash-out period of seven days in between. Saliva samples 
were taken after each rinse to measure the calcium, phosphate and fluoride 
levels using chromatography. The mineral content was also assessed using 
transverse microradiography. The findings of this study showed that significant 
calcium and phosphate levels were seen in the TM and TMP groups compared 
with the other groups. Additionally, the highest remineralisation ability was 
noted in TMP and TM (29.4 % and 24.2% respectively).  This study lacked any 
sample size calculation, and an additional weakness is the short study period 
(10 days), which could have influenced the results.  
In addition, Walker et al. (2006) used an in situ model to study the effect of 
CPP-ACP added to bovine milk on enamel remineralisation. Ten participants 




lesions. Once a day, the volunteers consumed 200ml of milk that contained 
either 2.0g or 5.0 g CPP-ACP/L or control bovine milk; this was over a three-
week period. The subjects crossed over after each treatment period with a 
wash-out period of seven days. The study used microradiography and micro-
densitometry tests to assess the mineral content. Significant enamel 
remineralisation in CPP-ACP groups was found compared with the control 
group. They also found that the CPP-ACP remineralisation effect was dose-
dependent.  
Moreover, Reynolds et al. (2003) compared the enamel remineralisation ability 
of CPP-ACP and different forms of calcium when delivered as a mouth rinse in 
a randomised double-blind crossover trial. Thirty volunteers were recruited and 
instructed to rinse for thirty seconds, three times daily, for five days. The 
participants crossed over to use each mouth rinse, which included: (i) oral rinse 
containing 2% CPP-ACP, (ii) oral rinse containing 6 % CPP-ACP, (iii) oral rinse 
containing un-stabilised slurry of CaCl2 and sodium phosphate and (iv) control 
de-ionized water, with a wash-out period of 28 days between study arms. The 
study found that only the mouth rinse containing CPP-ACP significantly 
increased the calcium and phosphate levels in the plaque. They also found that 
the effect CPP-ACP had on calcium and phosphate levels was dose-
dependent. This finding is consistent with a previous study carried out by 
Walker et al., (2006) 
Furthermore, in a systematic review published by Yengopal and Mickenautsch 
(2009), five clinical trials were pooled for meta-analysis. The review concluded 




contained CPP-ACP compared with chewing gum without CPP-ACP and 
control gum. However, this review only included clinical trials of a short-term 
period (7-21 days). 
In vivo studies  
In addition to the in vitro and in situ evidence, several in vivo experiments have 
been conducted to assess the ability of CPP-ACP technology in enhancing 
enamel remineralisation.  
Bailey et al. (2009) conducted a clinical trial to evaluate the effect of using 
CPP-ACP crème on white spot lesions that resulted from orthodontic treatment. 
Forty-five subjects with more than four hundred white spot lesions were 
recruited for this study. The subjects were randomised into two groups: Group 
1 received the CPP-ACP crème (n=23), Group 2 received a placebo crème 
(n=22). Participants were asked to apply the products twice a day after 
brushing with the fluoride toothpaste (1000ppm sodium fluoride) for twelve 
weeks. ICDASII Criteria were used to assess the progression and regression of 
the lesions. They found that more remineralised white spot lesions were 
significantly seen in the group treated with CPP-ACP crème compared with the 
placebo group. 
In a recent systematic review, the long-term remineralisation effect of using 
CPP-ACP in vivo was investigated. Eight studies were included in the review 
with 2376 participants and an average follow-up of 3-24 months. Of these eight 
studies, six were randomised controlled trials, and two were controlled trials. 
The review concluded that CPP-ACP had significant long-term remineralisation 




difference when compared with routine fluoride products. They also stated that 
the evidence to support the synergic effect between CPP-ACP and fluoride was 
not clear (Li et al., 2014).   
 
2.2.2.5 Interaction of CPP-ACP with Fluoride 
The combined effect of CPP-ACP and fluoride is believed to be due to the 
formation of CPP-stabilised amorphous calcium fluoride phosphate. This 
increases the concentration of bioavailable calcium and phosphate ions. It also 
enhances the integration of fluoride ions into the plaque (Cross et al., 2004). 
The synergic effect of CPP-ACP and fluoride has been investigated in the 
literature. Although there is considerable research supporting the use of CPP-
ACP as a remineralising agent, the benefits of using it as a regimen with 






2.2.2.5 a Studies reporting significant benefits of using CPP-ACP products over 
routine dental care on enhancing of enamel remineralisation  
Mendes et al. (2018) tested in vivo the effect of four different products (placebo, 
1.23% acidulated phosphate fluoride, CPP-ACP MI Paste™ and MI Paste 
Plus™) on the remineralisation of early enamel lesions on permanent anterior 
teeth. Thirty-six participants aged 5-13 years were divided randomly to receive 
one of the three products. All participants were instructed to brush with 1450 
ppm F twice daily in addition to the product they used. Lesions were 
periodically observed and assessed at baseline, one month and three months 
using a DIAGNOdent Pen. The results of this study indicated a significant 
improvement in terms of enamel remineralisation with MI Paste™ and MI Paste 
Plus™ at 90 days, compared with other groups. One interesting finding was 
that the significant difference of lesion intensity was only noticed between the 
groups after day 30. The main shortcoming of this study was that there was no 
sample size calculation. Furthermore, it was not clear who assessed the 
lesions and whether the assessors were calibrated. 
A further single-blind randomised controlled trial was carried out by 
(Altenburger et al., 2010). The study assessed the efficacy of a single daily 
application MI Paste™ on early carious pits and fissures. Thirty-two participants 
were randomised into control and test groups. The test group used MI Paste™ 
in addition to routine daily brushing with 1450 ppm F, whereas the control 
group had only the fluoridated toothpaste 1450 ppm F. DIAGNOdent. Visual 
assessments were used at baseline, day 8, day 14 and day 22 by two 




for the test group (P < 0.001) as compared with the control group. However, no 
significant difference was noted between the groups when using the visual 
assessment test. 
Reynolds et al. (2008) undertook a randomised, double-blind cross-over in situ 
study to assess the enamel remineralisation ability of different toothpaste 
slurries using microradiography and microdensitometry. Enamel sub-surface 
lesions were created and inserted into upper removable appliances worn by 
fourteen volunteers. Five products were tested (i) placebo, (ii) 1100 ppm NaF, 
(iii) 2800 ppm NaF, (iv) 2% CPP-ACP and (v) 2% CPP-ACP Plus 1100 ppm 
NaF. Participants were asked to rinse for one minute four times daily for two 
weeks. The results of the study showed significant residual remineralisation for 
the 2% CPP-ACP Plus 1100 ppm NaF group compared to other toothpastes.  
Adding to the evidence, a recent meta-analysis (Tao et al., 2018) compared the 
efficacy of fluoride alone to a combination of CPP-ACP and fluoride on early 
carious lesions. Ten randomised controlled trials with 559 patients were 
included in the study. Its outcomes were measured using four methods: laser 
fluorescence, quantitative light-induced fluorescence (QLF), lesion area and 
visual assessment scores. 
The study concluded that the combination therapy (CPP-ACP and Fluoride) is 
more effective than the monotherapy with fluoride only on early occlusal 
lesions. However, no significant difference was noted on the early proximal 
lesions. The main weakness of this study was that they defined the fluoride as 
any type of fluoride product, for example, fluoride mouth rinse, varnish or 




2.2.2.5 b Studies reporting no significant benefits of using CPP-ACP products 
over routine dental care on enhancing enamel remineralisation  
A randomised double-blind controlled trial was carried out to assess the 
advantage of using CPP-ACP-containing paste over the use of daily 1000 ppm 
fluoridated toothpaste in preventing caries progression and enhancing enamel 
remineralisation. In this study 296 high caries healthy pre-school children were 
randomised and assigned to experimental and control groups. The former 
received a daily application of 10% w/v CPP-ACP paste whereas the control 
group used a placebo paste. Both groups were brushing with fluoridated 
toothpaste (1000 ppm F). The (ICDAS) score and DMFS were assessed by a 
single assessor (a paediatric dentist) at baseline, six months, and one year. 
The results showed there was no significant difference between the groups and 
no added benefits of the CPP-ACP-containing paste over the use of daily 1000 
ppm F in the prevention of caries in primary teeth (Sitthisettapong et al., 2012). 
One of the main shortcomings of this trial was a high dropout rate with no 
intention to treat analysis performed. Furthermore, the pastes were only applied 
on school days, (the teachers applied the pastes), thus excluded weekends. 
Huang et al. (2013) published randomised single-blind study to assess the 
added benefit of using either MI Paste Plus™ or 22600 ppm fluoride varnish 
over the use of routine oral hygiene at home using fluoridated toothpaste (1100 
ppm F). Subjects (n=115) aged between 12 -20 years, with at least one white 
spot lesion, were randomly assigned to three groups. Group 1 received a twice-
daily application of MI Paste Plus™ for eight weeks and routine home care. 




home care. Group 3 received only routine home care. Photographs were taken 
at baseline and after treatment (8 weeks) and assessed by a group of dental 
health professionals and laypersons. The results showed no significant 
difference between the control and test groups. 
Furthermore, a double-blind randomised controlled trial (Beerens et al., 2010) 
evaluated the CPP-ACP effect on lesion regression and plaque composition. 
Fifty-four patients, diagnosed with white spot lesions following their orthodontic 
treatment, were randomly assigned to test and control groups. The former was 
instructed to use MI Paste Plus™ whereas the latter used a placebo paste. 
Both groups used the pastes as a supplement to their normal fluoridated 
toothpaste. Quantitative light-induced fluorescence (QLF) images and bacteria 
count (Streptococcus mutans, and Lactobacillus spp) were measured at 
baseline, six weeks and 12 weeks. The study concluded that there was a 
significant decrease in fluorescence loss and bacteria count in both groups 
following the three months of application. However, no statistically significant 
difference was detected between the test and control group. In this study, the 
concentration of the normal toothpaste used by both groups as the routine 
toothpaste was unspecified.  
A further single-blind randomised control trial was published by Bröchner et al. 
(2011). It assessed the efficacy of a daily application of CPP-ACP paste 
compared with the control group. Both groups brushed with fluoridated 
toothpaste (1100 ppm F) and received standard oral hygiene instructions. 
Three hundred twenty-seven white spot lesions were assessed using QLF and 




were consistent with the previous study Beerens et al. (2010) as both groups 
showed a significant reduction in fluorescence loss and lesion area compared 
to the baseline readings and no significant difference was found between the 
groups. 
In addition, a recent single-blind randomised control trial was carried out by 
Karabekiroğlu et al. (2017). They investigated the efficacy of the topical 
application of CPP-ACP paste for management of white spot lesions resulting 
from orthodontic treatment. In this study, 41 participants with white spot lesions 
following orthodontic treatment were randomly allocated to either experimental 
(CPP-ACP paste + 1450 ppm) or control groups (1450 ppm F only). The labial 
surface of the lesions was assessed at baseline and after three years of using 
the pastes using a DIAGNOdent pen, Gorelick Index and ICDAS II criteria. The 
study concluded that there was no extra benefit in using CPP-ACP over the use 
of routine fluoridated toothpastes (1450 ppm F). 
Moreover, Bataineh et al. (2017) conducted an in vitro study to investigate the 
remineralisation efficacy of CPP-ACP paste, CPP-ACP with 950 ppm F and 
2800 ppm F toothpaste, to compare these with 1450 ppm (positive control) and 
non-fluoridated toothpaste (negative control). The study used QLF as the 
method of assessment. QLF images were taken and analysed at baseline and 
after 21 days of pH cycling. The results showed that ΔQ (percentage 
fluorescence loss times the area of the lesion) of the negative control group 
was significantly lower compared to other groups. However, no significant 




Furthermore, Raphael and Blinkhorn (2015) carried out a systematic literature 
review to evaluate the effectiveness of Tooth Mousse™ (MI Paste™) and MI 
Paste™ (MI Paste Plus™) to prevent enamel demineralisation and enhance 
enamel remineralisation on white spot lesions. The study included 12 clinical 
trials that met the inclusion criteria. The results of the review stated that there 
were no significant benefits of using CPP-ACP products over routine brushing 





2.2.3 Functionalised tricalcium phosphate (f-TCP) 
Recent technology containing f-TCP has been produced by 3M ESPE Inc. In 
this technology, the remineralisation of enamel lesions results from milling TCP 
with sodium lauryl sulphate, which helps to inhibit unwanted premature 
interaction between calcium and fluoride. In addition, f-TCP maintains high 
levels of calcium, phosphate and fluoride, which enhances enamel 
remineralisation and inhibition of enamel demineralisation ( Amaechi, 2015; Jo 
et al., 2014). Currently, f-TCP is commercially available as Clinpro toothpaste™ 
with (5000 ppm NaF), Clinpro tooth crème™ with (950 ppm NaF) and fluoride 
varnish with (22600 ppm NaF). In the literature, several number of in vitro 
studies have investigated the remineralisation ability of f-TCP. However, few 
clinical trials have investigated its remineralisation effect.  
 
In vitro studies 
A recent QLF in vitro study was conducted to evaluate the remineralisation 
efficacy of Clinpro tooth crème™ (950 ppm NaF) and compare it with CPP-ACP 
crème, fluoridated toothpaste (1000 ppm NaF) and a negative control group 
(deionised water). Forty-five enamel specimens from twelve extracted 
premolars with artificial subsurface-like lesions were randomly allocated to 
each group. The agents were applied twice a day for two weeks. Baseline and 
after treatment readings were taken using QLF. The results showed a 
significant fluorescence per cent increase in f-TCP and CPP-ACP groups 




fluoridated and negative control groups respectively. This indicated more 
enamel remineralisation in the former groups (Jo et al., 2014).  
Using a scanning electron microscope (SEM) and DIAGNOdent tests, Joshi et 
al. (2013) compared the enamel remineralisation efficacy of f-TCP with 900 
ppm NaF, (CPP-ACP) and (CPP-ACPF) agents in an in vitro model. A total of 
76 permanent posterior teeth with artificial subsurface enamel-like lesions were 
randomly assigned to four groups: (i) CPP-ACP, (ii) CPP-ACPF, (iii) f-TCP (900 
ppm NaF) and artificial saliva. Samples were subjected to seven-day pH 
cycling with the agent being applied once a day for 4 minutes. All experimental 
groups showed a significant amount of remineralisation compared to the 
artificial saliva. The highest remineralisation amount was found in f-TCP 
followed by CPP-ACPF. However, no statistically significant difference was 
detected between the tested groups. One of the main shortcomings of this 
study was the short period of cycling, which might have affected the amount of 
remineralisation. In addition, the agent’s application did not follow the 
manufacturer’s recommendations. 
In a further in vitro study, Makoto Asaizumi et al. (2014) used X-ray 
microtomography (micro-CT) to assess the density of white spot lesions 
(WSLs) exposed to three different toothpastes: (i) fluoride-free toothpaste, (ii) 
Clinpro crème™ with (950 ppm NaF) and Clinpro toothpaste™ (5000 ppm 
NaF). Thirty bovine enamel slabs with artificial subsurface-like lesions were 
randomly assigned to three groups. Each group was subjected to one acid 
challenge and four applications of one of the experimental toothpastes for ten 




baseline and after treatment of ten days. At the end of the study, the Micro-CT 
findings showed an increased density of WSLs associated with teeth treated 
with toothpastes containing f-TCP compared with fluoride-free toothpaste. 
These results are consistent with another in vitro study that compared anti-
caries ability of Clinpro™ toothpaste (5000 ppm) with NaF toothpaste (5000 




In line with previous in vitro studies, Amaechi et al. (2012) conducted a 
randomised, crossover, double-blind in situ study to assess the enamel 
remineralisation ability of high fluoride toothpaste containing f-TCP technology. 
Thirty participants were recruited and wore appliances with six enamel slabs for 
each phase (three demineralised slabs and three healthy slabs). The study 
included three arms and participants were crossed over., Each arm is lasting 
28 days with a wash-out period of one week. The three arms were: (i) 5000 
ppm F with f-TCP (Clinpro 5000™), (ii) 5000 ppm NaF and (iii) non- fluoridated 
toothpastes. The subjects were instructed to brush twice a day using the 
assigned toothpaste for each period. Using surface microhardness and 
transverse microradiography, lesions were assessed at baseline and after 
treatment. It was found that both fluoridated toothpastes significantly reduced 
enamel demineralisation and enhanced enamel remineralisation compared with 




Clinpro 5000™ had resulted in greater remineralisation compared with the 
5000 ppm F toothpaste, 114% and 86.5% respectively.  
Moreover, Vanichvatana and Auychai (2013) carried out a 14-day in situ, 
randomised controlled double-blind trial to assess and investigate the 
remineralisation efficacy of Clinpro Tooth Crème™ (900 ppm F) and CPP-
ACPF (950 ppm F) and compare these to that of fluoridated toothpaste (1000 
ppm NaF). The study had three different arms and participants (n=9) were 
crossed over using each toothpaste with a wash-out period of eight days. The 
CPP-ACPF (MI Paste™) in this study was used as a regimen after brushing 
with fluoridated toothpaste. A polarised-light microscope was used to assess 
the lesion area at baseline and at the end of day 14 of each arm. The study 
showed that there was a significant reduction in lesion areas in all tested 
groups. The authors concluded that Clinpro Tooth Crème™ produced a similar 
remineralisation effect to the fluoridated toothpaste and no extra benefits were 
noticed when using CPP-ACPF as a regimen with fluoridated toothpaste. One 
of the limitations of this study was that the participants did not wear the 
appliances all the time. They were advised to wear them at least 12 hours per 
day. The other limitation was the short period of the study. In addition, there 
was no clear sample size calculation. 





2.3 Methods of study design used in caries research  
Enamel demineralisation and remineralisation can be assessed using different 
models which include in vitro, in situ and in vivo models. Well-designed 
randomised controlled trials (RCTs) are considered the gold standard method. 
However, such clinical studies are time-consuming and costly (White, 1995). 
 
2.3.1 In vitro 
This type of study simulates the oral environment effects in laboratory settings. 
It can give meaningful information about enamel status under controlled 
conditions. The in vitro model is the most common model used for caries’ 
research. In a recent systematic review that investigated the common models 
used for recent cariology research, in vitro models were the most frequent 
(84%) followed by in situ and in vivo model (15% and 1%) respectively (Yu et 
al., 2017). 
Its advantages are that it can be a good alternative system as it is simple and 
reproducible. In addition, it generally requires less time and is relatively 
inexpensive compared to the RCT clinical studies. Another advantage is that 
the in vitro model offers more control over the experimental conditions 
compared to other systems. Furthermore, there are less restrictive ethical 
requirements required (Yu et al., 2017; White, 1995). 
However, there are several limitations associated with in vitro models. The 
main disadvantage is the difficulty to mimic the complex oral environment 




design of the model used. Furthermore, artificial caries’ characteristics can be 
different from actual caries (Yu et al., 2017; White, 1995). 
 
2.3.2  In situ 
Zero, (1995) defined the in situ caries model as “the use of appliances or other 
devices which create defined conditions in the human mouth that simulate the 
process of dental caries”. The in situ model can be described as a bridge 
between in vitro and in vivo models. The main components of in situ caries are 
tooth substance (enamel or dentine), plaque formation, caries challenge; 
obtained from participants’ diet or controlled and time determined by the 
investigator. Unlike epidemiological studies, in situ studies require relatively 
fewer volunteers and a shorter period of time to avoid irreversible damage to 
the tissue (Zero, 1995). 
The in situ system offers several advantages over other models. The main one 
is that it takes place inside the oral environment unlike in vitro experiments. 
This allows for several important biological factors to be considered like the role 
of saliva and plaque. Another advantage is that it provides more control over 
the experimental variables compared to clinical trials. Its short-term feature is 
another merit since this can help to overcome ethical challenges  (Zero, 1995). 
Nevertheless, the in situ model has several disadvantages. The foremost 
limitation is that due to the nature of the model, the sample size is usually 
small. This may raise concerns about applying the results to wider populations. 
Another key drawback of this model is that it is highly dependent on 




compliance might have a major impact on the outcome. In addition, this 
technique needs more ethical requirements compared to in vitro models. The 
technique is also demanding, which requires extensive resources and clinical 
expertise (Zero, 1995). 
 
2.3.2.1 In situ study design 
Zero (1995) noted several factors that need to be considered when designing 
an in situ model, which are set out in the following paragraphs.  
 
Number of participants: 
As discussed previously, the sample size is usually small due to the nature of 
the in situ model (up to 40 participants). It is important to obtain a sample size 
based on a validated sample size calculation. 
 
The use of control:  
Based on the research aims, appropriate positive and negative control should 
be considered. This can be, for example, using fluoride-free toothpaste as a 
negative control in fluoride studies.  
 
The cross-over or parallel designs: 
This needs to be determined based on the research type, resources and study 
aim. The advantages of using a cross-over design are that it requires a 




on the outcomes. Therefore, a wash-out period needs to be considered when 
choosing this design. The wash-out period can be one week, two weeks or 
even longer(Zero,1995; Stephen et al. 1992).  
 
Length of experimental period: 
Based on the type of in situ model and research question, the study period can 
range from as short as 45 minutes up to six months.  
 
The caries challenge: 
Several methods can be used as a dietary challenge. The most common way is 
to use the individual’s normal diet (Zero 1995). Modifying a participant’s diet is 
another method utilised (Hall et al., 1995).  
 
Standardisation: 
It is important to standardise the oral condition as much as possible. The aim is 
to minimise the variations between participants. An example of how to do this is 
to standardise the oral hygiene practice. This was achieved in our model by 
asking participants to use only the assigned toothpaste for each arm. No other 
fluoride-containing food or products were used during the study. Other factors 
like saliva and medical history were carefully considered in our inclusion and 





The compliance assessment: 
As mentioned earlier, the in situ model is largely dependent on participants’ 
compliance. Therefore, compliance needs to be assessed, and several 
methods have been suggested to evaluate this. A common way is to use a 
diary in which volunteers complete a daily form. Another way is to measure the 
dispensed products before and after. It is also important to realise that this type 
of design is dealing with human volunteers. Thus a realistic protocol is 
necessary to avoid poor compliance.  
2.3.2.2 In situ models used for demineralisation and remineralisation 
studies  
Various in situ methods and designs have been used for demineralisation and 
remineralisation studies. Three main designs have been discussed in the 
literature: the banding model, crown single-section model and the removable 
appliances. Of these, the removable appliance technique is the most commonly 
used method (Øgaard, 1990).  
The removable appliances design has the advantage of allowing normal oral 
hygiene with minimal disturbance to the samples. However, this technique 
relies on patient compliance. Several designs have been used for in situ 
removable appliances. For example, Shen et al. (2001) used an upper 
removable acrylic appliance that covered a palate of the posterior teeth with 
two troughs to house the slabs. This technique was used by Vanichvatana and 
Auychai (2013) with a slight modification (Figure 2-2). The upper removable 
appliance design is used in 68% of in situ cariology research studies 




The removal appliance introduced by  Koulourides et al. (1974) has a labial 
arch with two acrylic buccal posterior flanges and metal clasps to aid retention. 
The substrates are attached to the appliances and secured with sticky wax. In 
addition, a gauze or mesh can be used to accumulate plaque (Figure 2-3)  
 
Figure 2-2 Upper removable acrylic appliance 













2.3.2.3 Substrates used for in situ models 
 
Different types of substrates have been used in different cariology in situ 
models. The most common substrate is the slabs derived from human enamel 
and dentine tissues. Other materials have also been used, including shark 
enamel, human root tissue and bovine enamel. Bovine enamel is good and the 
most common alternative for human enamel. (Table 2-1) summarises the main 
variations between human and bovine dental tissue (Hollanders et al., 2018; 





Table 2-1: Main variations between human and bovine dental tissues  
Characteristic 
 
Human dental tissue  Bovine dental tissue  
 
Dentinal tubules   
 
 
More dentinal tubules  
 









Tissue density  
 
 
Less compared to 
bovine  
 







compared to bovine 
 
Less variation 





Higher than bovine  
 









2.3.3 In vivo 
 
In vivo models are experiments carried out in living organisms, on living 
tissues. This takes into account different biological and chemical factors 
occurring inside the living organism. In dental caries’ research, such models 
are less common compared to others, as discussed previously (Hollanders et 
al., 2018). The most common example of this system is using teeth planned for 
orthodontic extraction in dental studies (Featherstone, 1996). The main 
advantages of this model for cariology are that it uses the natural oral 
environment like saliva, plaque and the teeth. It also considers the normal diet 
of the organism, which makes the results more relevant (Featherstone, 1996). 
However, several limitations are associated with this system. It is time-
consuming and expensive to undertake. In addition, as with the in situ model, it 
relies mainly on patient compliance. Furthermore, it is difficult to run over a long 
period due using vital tissues and participant compliance. Another challenge is 






2.4 Methods of mineral assessment 
As described earlier, the enamel demineralisation and remineralisation are 
related to the process of losing or gaining minerals. Several methods have 
been used to assess the enamel de/remineralisation(Arends and Ten Bosch, 
1992).  This part will discuss the most common techniques used to evaluate the 
change in mineral content.  
 
2.4.1 Microhardness  
Microhardness technique measures the resistance of the dental hard tissue 
against the load produced from indention process. The indenter can be done 
using either Knoop or Vickers diamond which is placed on the dental hard 
tissue for a specified amount of time. The indentation-length left can then be 
measured in micromillimeter using a microscope. The microhardness technique 
is considered as an indirect method to assess mineral loss and gain (White et 
al., 1992; Arends and Ten Bosch, 1992). 
Microhardness techniques are classified into two methods, Surface 
microhardness (SMH) and Cross-sectional microhardness (CSMH).  In SMH 
the indenter is placed perpendicular on a highly polished flat dental sample. 
The advantages of this method include that it is an easy and inexpensive 
method. It is also non-destructive which allows for multiple assessments for the 
same sample. However, a flat highly polished surface is required in order to 
obtain a reliable result. In addition, it does not give information about mineral 




described by Zero et al. (1990) is that this technique is effective up to limited 
level of lesion depth (Arends and Ten Bosch, 1992). 
Whereas in CSMH the indenter is used parallel to the dental tissue; using this 
method offers several advantages include; being able to obtain more details 
about the mineral profile. Also, this technique provides quantitative information 
about mineral loss or gain. However, (CSMH) measurement excludes the outer 
25 micromillimeters of the specimen (Arends and Ten Bosch, 1992). 
Lippert and Lynch (2014) carried out an in vitro study to compare the ability of 
surface microhardness (SMH) using Knoop or Vickers diamond with 
Transverse Microradiography (TMR) to assess early enamel lesion formation.  
Bovine enamel (n=90) and human enamel (n=90) were subjected acid 
challenge to create artificial enamel subsurface lesions and divided into six 
treatment groups. Each group received a further demineralisation challenge 
with different times. SMH assessments were obtained at baseline and after 
demineralisation for each group. Lesions were also assessed using Transverse 
Microradiography (TMR). The results showed that there was a positive 
correlation between indentation length and demineralisation times. However, a 
state of plateau was noticed after 40 hours demineralisation time. The SMH’s 
results were relatively consistent with TMR’s findings. The study also found a 





2.4.2 Quantitative light-induced fluorescence (QLF) 
Since 1994, QLF has been widely used as a method of assessment for de and 
remineralisation. There are several parameters that can be obtained from QLF. 
The main three parameters that are used for assessment of remineralisation 
and demineralisation are summarised in Table 2-2 (Lippert and Lynch, 2014) 






% Percentage fluorescence loss with 
respect to the fluorescence of sound 
tooth tissue. Related to lesion depth. 
 
ΔQ 
%px2 Percentage fluorescence loss with 
respect to the fluorescence of sound 








Area with ΔF equal to or smaller 
than a specific threshold value of ΔF 
 
 
The QLF principal based on the concept that change in mineral content of the 




demineralisation absorbs less light secondary to increase in its porosity 
(Karlsson, 2010). 
Several studies have been conducted to assess the QLF validity. An in vitro 
study compared the ability of QLF and digital photography to measure 
remineralisation with the gold standard Transverse Microradiography (TMR). 
Forty slabs with artificial enamel subsurface like lesions were obtained from 
human enamel. The specimens were treated with remineralising agents for ten 
days. Baseline and after treatment readings were carried out using QLF and 
digital photography and compared with TMR readings. The results revealed a 
statistical positive correlation between the three methods; gold standard and 
QLF (r = 0.63), the gold standard and digital photography (r = 0.59), and digital 
photography and QLF (r = 0.64). The authors concluded that QLF and digital 
photography can give valuable information about mineral loss or gain and can 
be used where the destruction of the specimens is not an option. They also 
stated that QLF was easier to analyse and had less variability compared the 
digital photography (Cochrane et al., 2012). 
Furthermore, repeatability and reproducibility of the QLF were assessed in an 
in vivo study. Fifteen Images were captured and analysed by three different 
specialists. The results of the study showed high inter-examiner reliability for 
three analysts and excellent reproducibility (Tranæus et al., 2002). These 
results were in line with another in vitro study (Pretty et al. 




The major advantage of this technique is that it is a non-destructive method 
that can be used in longitudinal studies. In addition, it offers an advantage of 
reducing time and cost for clinical studies (Higham et al., 2005). 
However, the main limitation that associated with this system is that the QLF 
readings can be misinterpreted due to the presence of stains, plaque and 
dehydration (Al-Khateeb et al., 2002).   
 
2.4.3 Transverse Microradiography (TMR) 
Transverse Microradiography (TMR) is the most common type of 
microradiography.  It is now considered as the gold standard for mineral 
assessment as it has a high accuracy of evaluation of minerals’ loss or gain. In 
addition, (TMR) gives valuable information about mineral distribution. 
In this technique, thin enamel slabs are cut (µm90) and oriented 
perpendicularly to the tooth surface. The samples alongside a calibration 
aluminium wedge are placed in a film and subjected to irradiation with 
monochromatic x-rays. Two main parameters can be calculated, mineral loss 
(vol%.μm) and lesion depth (μm), by analysing the absorption of the x-rays 
(Arends and Ten Bosch, 1992). 
The main limitation of this approach is that it is a destructive method. In 
addition, misinterpretation of data can result from the presence of ions that has 






2.5 Research aims and hypotheses 
2.5.1 Aim 
The aim of this study was to investigate the efficacy of two different caries 
preventive regimen and therapies: MI Paste Plus combined with fluoride 
toothpaste 1450 ppm F (0.32% w/w sodium fluoride); f-TCF Clinpro tooth 
crème 950 ppm F (0.21% w/w sodium fluoride) and fluoride toothpaste 1450 
ppm F (0.32% w/w sodium fluoride), on de/remineralisation of dental enamel 
under cariogenic challenge in an in situ randomised, cross-over study design. 
 
2.5.2 Objectives  
1- To assess and compare the effect of a different caries preventive regimen 
and therapies: MI Paste Plus combined with fluoride toothpaste 1450 ppm 
F (0.32% w/w sodium fluoride); Clinpro tooth crème 950 ppm F (0.21% w/w 
sodium fluoride) and fluoride toothpaste 1450 ppm F (0.32% w/w sodium 
fluoride), on progression/regression of artificial subsurface carious lesions 
in situ, using quantitative light fluorescence (QLF) technology. 
2- To assess and compare the effect of a different caries preventive regimen 
and therapies: MI Paste Plus combined with fluoride toothpaste 1450 ppm 
F (0.32% w/w sodium fluoride); Clinpro tooth crème 950 ppm F (0.21% w/w 
sodium fluoride) and fluoride toothpaste 1450 ppm F (0.32% w/w sodium 





2.5.3 Null hypotheses 
1. There is no difference between 0 ppm F toothpaste; MI Paste Plus combined 
with fluoride toothpaste 1450 ppm F (0.32% w/w sodium fluoride); Clinpro tooth 
crème 950 ppm F (0.21% w/w sodium fluoride) and fluoride toothpaste 1450 
ppm F (0.32% w/w sodium fluoride), on progression/regression of artificial 
subsurface carious lesions in situ as measured by QLF. 
2. There is no difference in the effect of different caries preventive regimen and 
therapies: MI Paste Plus combined with fluoride toothpaste 1450 ppm F (0.32% 
w/w sodium fluoride); Clinpro tooth crème 950 ppm F (0.21% w/w sodium 
fluoride) and fluoride toothpaste 1450 ppm F (0.32% w/w sodium fluoride), on 
progression/regression of artificial subsurface carious lesions in situ as 
measured by QLF. 
3. There is no difference between 0 ppm F toothpaste; MI Paste Plus combined 
with fluoride toothpaste 1450 ppm F (0.32% w/w sodium fluoride); Clinpro tooth 
crème 950 ppm F (0.21% w/w sodium fluoride) and fluoride toothpaste 1450 
ppm F (0.32% w/w sodium fluoride), on the inhibition of the demineralisation 
process in dental enamel under cariogenic challenge in situ as measured by 
SMH. 
4. There is no difference in the effect of a different caries preventive regimen 
and therapies: MI Paste Plus combined with fluoride toothpaste 1450 ppm F 
(0.32% w/w sodium fluoride); Clinpro tooth crème 950 ppm F (0.21% w/w 
sodium fluoride) and fluoride toothpaste 1450 ppm F (0.32% w/w sodium 
fluoride) on the inhibition of the demineralisation process in dental enamel 





3.0 MATERIALS AND METHODS 
3.1 Study Design 
This is a randomised, crossover design study in situ. The study comprise of 
four study arms and making a total of 4 months for the entire study. Each study 
arm comprise a washout period of one week before a 21 day treatment period. 
Participants were wearing an intra-oral lower removable appliance continuously 
(except at meal times, when brushing their teeth and whilst drinking) for 3 
weeks during each period. The participants then started a wash out period for a 
minimum of one week in order to start next arm.  
During the washout period, the participants used fluoride-free toothpaste for 
tooth brushing. During the treatment period, the cariogenic challenge 
comprised of five dipping per day in a 12% sucrose solution and volunteers 
dipped the appliance in 50 ml of the sucrose solution for two minutes on each 
occasion. Volunteers also dipped their appliances twice daily for 2 minutes, in 
one of the test toothpaste slurry, which was prepared by mixing 1 gram of the 
toothpaste with 5 ml of distilled water.  
For the regimen group, volunteers dipped their appliances twice daily for two 
minutes in 1450 ppm sodium fluoride toothpaste slurry. Also, once daily at night 
time, the dipping of the appliances in 1450 ppm sodium fluoride toothpaste 




ACP, 900ppm sodium fluoride) slurry for three minutes. These procedures were 
repeated for 21 days for each test period. The enamel subsurface lesions 
images and remineralisation were assessed using a Quantitative Light Induced 
Fluorescence (QLF) system under controlled conditions at baseline and after 
treatment. Intact enamel slabs and demineralisation were assessed using 
Surface Microhardness under controlled conditions at baseline and after 
treatment. 
3.2 Ethical and regulatory aspects 
Ethical approval for this study was sought from the Dental Research Ethics 
Committee of the University of Leeds at (Appendix 1). Informed consent was 
obtained from all participants. The Principal Investigators (PI) ensured that this 
study was conducted in full conformance with the laws and regulations of the 
country in which the research is conducted and the Declaration of 
Helsinki/Venice/Tokyo/Hong Kong/South Africa (1996). 
3.2.1 Training and calibration 
Prior to the commencement of the study, the Principal investigator (PI) obtained 
Good Clinical Practice (GCP) and laboratory training. In addition, he was 
calibrated to use of Diamond Wire cutting machine, QLF and Microhardness 





3.2.2 Sample size and power calculation 
Based on data from previous in vivo study by Manal Allammari et al. (2010) 
Statistical advice was sought and the sample size was calculated. A sample 
size of 12 was required to achieve 91% power to detect a difference of 5% in 
ΔF between four materials with an estimated standard deviation of 4.5% and 
with a significance level (alpha) of 0.05 using one-way ANOVA-test. However, 
with around 15% dropout rate, 14 subjects were recruited to achieve the same 
power. 
3.2.3 Recruitment and selection of participants  
Recruitment was through using poster advertisement at the University of Leeds 
(Appendix 2). Fourteen subjects were recruited and completed the study. The 
age range of the volunteers was 22-60 years old. Volunteers were mainly from 





3.2.4 Inclusion Criteria 
 Minimum of 18 natural teeth, 
 No sign of active periodontal disease, 
 Medically fit and well, 
 Provide written informed consent, authorisation for the release of health 
information for research and medical history information before their 
participation, 
 Between 18 to 65 years old in good health with no evidence of infectious 
diseases, 
 Minimum unstimulated whole saliva flow rate  0.2 ml/min and a 
stimulated whole saliva flow rate  0.8 ml/min, 
 Be able to wear the appliances 24 as required by the protocol, 
 Be able to comply with the experimental procedures. 
3.2.5 Exclusion criteria  
 Signed informed consent not obtained by the volunteers, 
 Adults taking drugs that affect the saliva rate, 
 Volunteers with a complex medical history (e.g. epileptic subjects, 
subjects at risk of infective endocarditis, or pregnant/nursing subjects), 
 Volunteers who had a course of antibiotics in the last four weeks, 
 Volunteers who had antimicrobial treatment in the last two weeks, 
 Volunteers with complex dental history such as periodontitis, rampant 
caries or salivary dysfunction, 
 Volunteers with an allergy to any of the materials used in the study, 
 Have any medical condition that could be expected to interfere with the 




 Be taking any medication that could potentially react with the testing 
products, 
 Demonstrate an inability to comply with study procedures, 
 Volunteers showing signs of moderate or severe tooth wear.  
3.2.6 Subject withdrawal criteria 
Subjects had the right to withdraw from the study at any time for any reason.  
The investigator also had the right to withdraw subjects from the study if the 
subject failed to comply with the study protocol, experienced concurrent illness 
or adverse events. 
3.2.7 Subject replacement 
If a subject discontinues before completing all study assessments, a 
replacement subject would have entered into the study following an agreement 
between the investigator and the ethics committee. 
3.2.8 Investigational products  
1- Non-Fluoride toothpaste (the Boots Company PLC, Nottingham, England). 
2- Fluoride toothpaste 1450 ppm F (0.32% w/w sodium fluoride) (Colgate cool 
stripe. Colgate–Palmolive (UK) Ltd, Guildford, England). 
3- MI Paste Plus 10% w/v CPP-ACP, 900 ppm F (0.2% w/w sodium fluoride) 
(GC MI Paste Plus™, GC Corp, Tokyo, Japan) + Fluoride toothpaste 1450 ppm 
F (0.32% w/w sodium fluoride) (Colgate cool stripe. Colgate–Palmolive (UK) 




4- 3M ESPE Clinpro Tooth crème - (Functionalized Tricalcium Phosphate + 






3.3 Test methods used in de/remineralisation evaluation: 
Enamel remineralisation was assessed in this study by using Quantitative 
Light-Induced Fluorescence (QLF) whereas enamel demineralisation was 
measured using Surface Microhardness (SMH). 
3.3.1 Quantitative Light-Induced Fluorescence (QLF) 
QLF was previously described in Section (2.4.2).  
3.3.1.1 Teeth selection and cleaning   
Bovine incisors were collected and stored in distilled water and 0.1% thymol 
(Sigma Aldrich, thymol 98%) at room temperature. Any soft tissue remnants 
were removed using a spoon excavator and a toothbrush with pumice powder 
and stone. The teeth were then visually inspected for any defect or caries. Also, 
all teeth were examined by trans-illumination and transmitted light using low-
power microscopy (Leitz, Wetzlar®, Germany) to confirm absence of stains, 
caries, defects or cracks. Suitable teeth were selected. 
3.3.1.2 Preparation of the enamel slabs for QLF analysis: 
The selected teeth were mounted on plates using ‘green stick’ compound (Kerr, 
UK) on plates before teeth sectioning. The crowns were then sectioned using 
diamond wire saw cutting machine (Well@Walter EBNER, CH-2400 Le Loche). 




was approximately 4mm x 4mm x 2mm.
 
Figure 3-1 Diamond wire saw cutting machine (Well® Walter EBNER, CH-
2400 Le Loche). 
 
3.3.1.3 Preparation of the Artificial Enamel Subsurface Lesion for QLF 
A demineralising acid gel was used.to create enamel sub-surface like lesions  
The preparation of demineralisation system: acidified hydroxyethyl 
cellulose gel  
The demineralising gel was produced by mixing 0.1 M sodium hydroxide (BDH 
Analar Grade) and 0.1 M lactic acid (Sigma Aldrich D/L GPR 87% Lactic acid) 
to achieve a pH value of (4.5). 6% w/v hydroxyethyl cellulose (Sigma Aldrich) 




similar to that of “wallpaper paste” is achieved. The mixture was left to settle for 
a period of 24 hours. The demineralising gel was poured into the universal 
tubes “Sterilin” into which the mounted teeth were submerged. The enamel 
slabs were varnished with two layers of an acid resistant, coloured Nail varnish 
(Max Factor “Glossfinity”) except for a window approximately 1mm by 2 mm. 
the slabs then immersed in the acid gel for a period of ten days. The slabs then 
removed and washed with distilled water. Methanol was used to remove the 
nail varnish to prepare the slabs for baseline QLF readings  
3.3.1.4 Quantitative light-induced fluorescence (QLF) analysis  
QLF readings were taken at baseline and at the end of each arm in a dark 
room using the QLF machine (QLF-D Biluminator™ 2 Inspektor Research 
Systems BV, Amsterdam, The Netherlands), under controlled conditions 
(Figure 3-2). 
QLF-D Biluminator™ 2 consists of a Biluminator™ mounted on a Single Lens 
Reflex (SLR) camera fitted with a 60 mm macro lens. The Biluminator™ 
provides the light sources and filters for making white-light and QLF™-images.  
Fluorescence images of all enamel specimens were captured with a ‘Live 
View’-enabled digital full-sensor SLR camera (model 550D, Canon, Tokyo, 
Japan) at the following setting: shutter speed of 1/30 s, aperture value of 6.7, 
and ISO speed of 1600. All digital images were stored automatically on a 
personal computer with image-capturing software (C3 version 1.16; Inspektor 
Research Systems). All fluorescence images were examined with analysing 
software (QA2 version 1.16; Inspektor Research Systems). The analyses were 




The study images were captured in a standardised and controlled environment. 
These were achieved by using the same camera position, angels and distance. 
The QLF camera was fixed at a position that provided optimum illumination of 
the enamel block surface. To minimise the hydration effect, the slabs were 
dried for 15 seconds before capturing as recommended by (Al-Khateeb et al., 
2002). 
 
Figure 3-2 QLF machine, the SLR camera attached to the stand with 
standardised distance from the enamel slab.  
 
The operator (MA) drew a patch around the white spot lesion area with its 
border on sound enamel (Figure 3-3). Inside this patch, the fluorescence levels 




surrounding sound enamel. The percentage difference between the 
reconstructed and the original fluorescence levels was calculated. The same 
area of interest was used for the baseline and endpoint white spot lesion image 
identification. 
 
Figure 3-3: QLF image taken with the blue light shows the demineralised 
lesion in the centre of the enamel slab as well as a patch drawn 
around the lesion with the border in sound enamel. 
 
Demineralised areas appeared as dark spots. The fluorescent radiance of a 
white spot lesion viewed by QLF was lower than that of sound enamel. In order 
to enable calculation of loss of fluorescence in the white spot lesion, the 
fluorescent radiance of sound tissue at the lesion site was reconstructed by 
interpolation from the radiance of the sound tissue surrounding the lesion. 
Fluorescence radiance levels less than 95% of reconstructed sound 
fluorescence radiance levels were considered to be artificial early caries lesions 




fluorescence loss. The difference between the measured values and the 
reconstructed values gave the resulting fluorescence loss in the lesion. 
Three metrics were assessed for each enamel lesion: 
1. ΔF: Percentage fluorescence loss with respect to the fluorescence of 
sound tooth tissue. This is a measure of lesion depth (%).  
2. ΔQ: ΔF times the Area. Percentage fluorescence loss with respect to the 
fluorescence of sound tissue times the area. This is a measure of lesion 
volume (%px2).  





3.3.2 Knoop Microhardness (KMH) 
Knoop Microhardness (KMH) was previously described in Section (2.4.1). 
3.3.2.1 Teeth selection and cleaning 
Teeth selection and cleaning were previously stated in Section (3.3.1.1) 
3.3.2.2 Preparation of the Enamel Slabs for Microhardness testing  
The selected teeth were mounted on plates using ‘green stick’ compound (Kerr, 
UK) on plates before teeth sectioning. The crowns were then sectioned using 
diamond wire saw cutting machine (Well@Walter EBNER, CH-2400 Le Loche). 
The slabs were obtained from the buccal flat surface. The size of each slab 
was approximately 2mm width, 4mm length and 2 mm in depth. To ensure 
accuracy of the microhardness reading, the slabs were polished while wet 
using fine grit abrasive paper (P1000 Wet & Dry paper, 3M) in combination with 
5 µm and 1µm alumina paste used to remove the outermost enamel layer (100-






3.3.2.3 Baseline Microhardness Assessment: 
Each enamel slab was subjected to baseline microhardness testing before 
being placed in the in situ intra-oral appliances for the study.  After sterilisation, 
an assessment of the enamel microhardness was made using a Knoop 
indenter with a load of 100 g applied for 15 seconds.  Five indentations were 
applied and measured across the enamel specimen.  A clean, sterile indenter 
was used for reading the enamel slabs. 
 
Figure 3-4:  The computer-aided Duramin Indenter Machine (Struers A/S, 






Figure 3-5: Microscopic image of diamond shape indentation on the 
enamel surface of the enamel at baseline. 
  





3.3.2.4 Orientation of Microhardness Testing on Enamel Slabs: 
Indentation occurred on the buccal surface of a tooth only.  The surface was 
made flat and shiny during preparation processes to ensure an optimal surface 
for microhardness testing.  The indents on the slab were applied at five points 
across the enamel slab as shown below: 
     2 
4     1  5 
       3 
 
3.3.2.5 Indenter Sterilisation: 
Indenter sterilisation was conducted after microhardness testing of any 
potentially contaminated slabs using Virkon Surface disinfectant. 
3.3.2.6 Sterilisation and storage of enamel slabs 
Once the slabs were prepared, they were kept moist in de-ionised distilled 
water at room temperature (20oC). The slabs were immersed in 12% sodium 
hypochlorite for 24 hours to eliminate prions. The slabs were then stored damp 
in sealed containers and sent to the Department of Immunology of the 
University of Liverpool, where they were exposed to gamma radiation (4080 







3.3.3 Experimental appliance 
The appliance used in the study was a mandibular removable appliance, which 
was introduced by Koulourides et al. (1974). It consisted of a labial arch with 
two acrylic buccal posterior flanges and metal clasps to aid retention (Figure 3-
6). Two enamel slabs were secured in the buccal flange of the appliance for 
each phase. The enamel slabs were assigned to the left side of the appliance 
and secured in the buccal flange with sticky wax, care was taken to ensure that 
the wax did not cover the exposed surface of the enamel. The slabs were then 
covered by 0.15mm Dacron gauze and secured with sticky wax. The gauze 












3.4 Randomisation and blindness 
The randomisation of the enamel slabs for both QLF and Microhardness tests 
was applied in order to allocate them to the subjects. In addition, subjects were 
randomised in order to organise the order of the toothpastes they used. 
Randomisation was performed by using a randomisation website 
http://www.randomization.com (Appendix 3). When the slabs were analysed 
with QLF or Microhardness, the investigator (MA) did not know which group the 





3.5 Study procedures 
3.5.1 Informed consent 
Advertisement posters were placed at public areas at the University of Leeds. 
Participant information sheet was given to potential participants (Appendix 4). A 
minimum period of seven days was given to participants before they were 
invited for the first screening visit. After adequate explanation of study aims, 
methods and potential risks and benefits, an informed verbal and written 
consent was obtained by the chief investigator (MA) from participants prior to 
participation (Appendix 5). The date and time of the consent was then recorded 
in the participant’s records. 
3.5.2 Screening visit 
A subject screening record and a Case Record Form (CRF) was used to 
document the screening evaluation along with any reason for failure (Appendix 
6).  At the screening visit, a CRF was completed for all attended subjects. 
Eligible subjects were randomised to receive study products and a CRF was 
completed for all randomised subjects. The following were performed during 
assessed during the screening visit: 
3.5.2.1 Demography 





3.5.2.2 Medical History 
The investigator took the medical history of each subject including details of 
any relevant medical or surgical history, allergies or drug sensitivity. The 
Investigator also reported into the CRF details of any concomitant medications.  
3.5.2.3 Oral examination  
At the start of the study, the subject was given a dental examination to 
determine their decayed, missing and filled teeth (DMFT Index). The findings 
were recorded in the CRF.  
3.5.2.4 Salivary flow rate 
A referenced salivary flow rate (an unstimulated whole saliva flow rate  0.2 
ml/min and a stimulated whole saliva flow rate  0.8 ml/min) was measured to 
ensure that a standard remineralisation effect of the saliva of all volunteers was 
achieved.  
3.5.2.5 Measurements made for in situ oral appliances 
The subjects were seated in a comfortable position in a dental chair.  In order 
to protect clothing, the subject wore a bib.  The subjects used a dental mouth 
rinse to keep the oral cavity clean during the impression procedure.   
A colour coded transparent impression tray (Polytray Dentsply) was chosen to 
fit each subject.  The chosen tray was filled with an alginate impression 
material (Xantalgin®, Kulzer) and placed in the subject’s mouth to give an 
impression of the lower jaw/arch.  A wax bite was taken. The impressions and 
wax bite was disinfected in Perform-ID (Schulke & Mayr) before transporting to 




3.6 Treatment Phases 
3.6.1 Wash-in period 
In order to eliminate the effect of any carryover dental products, there was a 
wash-in phase for seven days prior to the start of the first arm of the study. 
Subject used fluoride free toothpaste during this period. Each participant had a 
wash-out period with non-fluoridated toothpaste between each study arm. 
3.6.2 Acclimatisation period 
The subjects wore the in situ oral appliances for 2-7 days before commencing 
arm one (i.e. concurrent with the wash-in phase of study arm 1). During this 
period subjects wore the appliances at all times (except when eating, drinking, 
or brushing their teeth). 
If the subject experienced discomfort, they returned to the study site for the 
appliance to be adjusted. They then continued with the acclimatisation period. 
3.6.3 Plaque build-up period 
At the start of each study arm, the in situ intra-oral appliances were disinfected, 
and two enamel slabs were inserted into each applaince. On the same or the 
following working day (Day-2) subjects were then fitted with the in situ intra-oral 
appliances containing the two enamel slabs. The subjects were given the 





The subject wore the in situ intra-oral appliances at all times (except when 
eating, drinking, brushing their teeth and exposure to the investigational 
products) for a minimum of 48 hours immediately prior to dosing. 
3.6.4 Investigational product use period 
Each subject wore their in situ intra-oral appliance (with the two enamel slabs) 
in their mouth for the entire duration of each study arm, i.e. from the start of the 
plaque build-up phase through to the removal of the two enamel slabs after 21 
days. Each subject was instructed to remove the in situ intra-oral appliances 
from their mouth and immerse it in the allocated investigational product as 
instructed for 21 days. 
3.6.5 Day 21 
On Day 21, the subjects returned to the study site.  Both enamel slabs were 
removed from the in situ intra-oral appliances.  The subjects returned their diary 
cards and used investigational product containers to site staff.  Subjects were 
asked if they had continued to comply with the study restrictions.  Any adverse 
events or concomitant medications were recorded in the CRF. 
At the end of each of the three study arms, the subjects left the in situ intra-oral 
appliances at the study site for preparation of the subsequent study arm. 
3.6.6 Washout 
In order to eliminate any effect of the previous product, the washout phase 





3.6.7 Follow up visit 
The participants attended a follow- up visit after the final visit. In this visit, 
medical history was checked, and optional application of fluoride varnish was 
delivered. Subjects also were advised to recommence use of fluoride-
containing toothpaste when brushing their teeth. 
3.7 Study regime 
The subjects were randomised to start with one of the test regimes using 
specially designed appliances with fixed enamel slabs. The study regime is 





Table 3-1: Study regimes of the four arms  






The subject wore the in situ intra-oral appliances at all times 
in their mouth (except when eating, drinking or brushing 
their teeth) for a minimum of 48 hours immediately before 
dispensing the study products. 
21 days During day, the participants dipped the appliance 5 times 
daily for two minutes into 12%- 50 ml sucrose solution.  
Volunteers dipped their appliances twice daily for 2 minutes, 
in slurry of the experimental materials which was prepared 
by mixing 1 g of the toothpaste with 5 ml of distilled water. 
For the regimen group, volunteers dipped their appliances 
twice daily for two minutes in a toothpaste slurry of 1450 
ppm sodium fluoride followed with a dipping in a slurry of  
MI Paste Plus (10% w/v CPP-ACP, 900ppm sodium 

































The subject wore the in situ intra-oral appliances at all times 
in their mouth (except when eating, drinking or brushing 
their teeth) for a minimum of 48 hours immediately before 




21 days During day, the participants dipped the appliance 5 times 
daily for two minutes into 12%- 50 ml sucrose solution.  
Volunteers dipped their appliances twice daily for 2 minutes, 
in slurry of the experimental materials which was prepared 
by mixing 1 g of the toothpaste with 5 ml of distilled water. 
For the regimen group, volunteers dipped their appliances 
twice daily for two minutes in a toothpaste slurry of 1450 
ppm sodium fluoride followed with a dipping in a slurry of  
MI Paste Plus (10% w/v CPP-ACP, 900ppm sodium 













The subject wore the in situ intra-oral appliances at all times 
in their mouth (except when eating, drinking or brushing 
their teeth) for a minimum of 48 hours immediately prior to 
dispensing the study products. 
21 days During day, the participants dipped the appliance 5 times 
daily for two minutes into 12%- 50 ml sucrose solution.  
Volunteers dipped their appliances twice daily for 2 minutes, 
in  slurry of the experimental materials which was prepared 
by mixing 1 g of the toothpaste with 5 ml of distilled water. 
For the regimen group, volunteers dipped their appliances 
twice daily for two minutes in a toothpaste slurry of 1450 
ppm sodium fluoride followed with a dipping in a slurry of  
MI Paste Plus (10% w/v CPP-ACP, 900ppm sodium 


































The subject wore the in situ intra-oral appliances at all times 
in their mouth (except when eating, drinking or brushing 
their teeth) for a minimum of 48 hours immediately before 




21 days During day, the participants dipped the appliance 5 times 
daily for two minutes into 12%- 50 ml sucrose solution.  
Volunteers dipped their appliances twice daily for 2 minutes, 
in slurry of the experimental materials which was prepared 
by mixing 1 g of the toothpaste with 5 ml of distilled water. 
For the regimen group, volunteers dipped their appliances 
twice daily for two minutes in a slurry of toothpaste 1450 
ppm sodium fluoride followed with a dipping in a slurry of  
MI Paste (10% w/v CPP-ACP, 900ppm sodium fluoride) for 







3.8 Flow Charts 
3.8.1 Flow chart regime of the study arms using fluoride 1450 ppm 


















Plaque accumulation on appliance (2 days) 
 















Enamel slabs were removed after 21 days, the intact slabs were assessed with 
Surface Microhardness and the slabs with lesions were assessed using QLF 
 
Repeat with 2nd and 3rd test toothpastes 
 
Wash in period (1 week) 
 
Screening (Salivary Flow, DMFS Score) 
 
(Salivary  Flow, pH Drop, DMFS Score) 
 
For (21 days) the participants dipped the appliance 5 times/day for two minutes into 12% 
sucrose + dipping the appliances twice/day for 2 minutes in a toothpaste slurry of the 




 in a slurry of the experimental materials which will be prepared by mixing 1 g 
of the paste with 5 ml of distilled water. 





3.8.2 Flow chart regime of the study arm using MI Paste Plus(10% 
w/v CPP-ACP, 900 ppm sodium fluoride) + fluoride toothpaste 


















Enamel slabs will be removed after 21 days, the intact slabs were assessed with 
Surface Microhardness and the slabs with lesions were assessed using QLF 
 
Screening (Salivary Flow, DMFS Score) 
 
(Salivary  Flow, pH Drop, DMFS Score) 
 
Wash in period (1 week) 
 















Plaque accumulation on appliance (2 days) 
 
Preparation of in situ devices 
 
For (21 days) Volunteers dipped the appliance 5 times/day for two minutes into 12% sucrose + 
dipping the appliances twice/day for two minutes in a toothpaste slurry of 1450 ppm sodium 
fluoride followed with a dipping in a slurry of MI Paste Plus (10% w/v CPP-ACP, 900ppm) 




 in a slurry of the experimental materials which will be prepared by mixing 1 g of the 





Volunteers’ compliance was checked using the following methods: 
 Each volunteer had a case record form to monitor and record each step 
during the study (Appendix 5).  
 By checking the dipping diary during volunteers’ visits. The subject 
recorded the date, start time and duration of each immersion in the diary 
card provided.   
 By collecting the used sucrose solution bottles and measuring the 
remnants of each bottle and record it in disposed form. 







4.1 Quantitative Light-induced Fluorescence (QLF) Results  
Three main parameters for QLF were statistically analysed, these were:  
1. ΔF: Percentage fluorescence loss with respect to the fluorescence of 
sound tooth tissue. This is a measure of lesion depth (%).  
2. ΔQ: ΔF times the Area. Percentage fluorescence loss with respect to the 
fluorescence of sound tissue times the area. This is a measure of lesion 
volume (%px2).  
3. Area: The surface area of the lesion expressed in pixels2 (px2). 
 
4.1.1 The mean fluorescence loss ΔF  
4.1.1.1 Normality of ΔF data 
Shapiro-Wilk and Kolmogorov-Smirnov tests were used to assess the data 
normality of ΔF. The tests gave a P value of >0.05 which indicated that the data 
was normally distributed. 
The box- and- whisker plots show (Figure 4-1) the median, maximum value and 
minimum value, first and third quartiles within the data set. It can be seen that 






Figure 4-1: Boxplot for the distribution of the ΔF values at baseline, 
demonstrating the upper and lower values, Standard deviation (SD) and 
the median value of the data. 
 
One-way ANOVA test was performed to assess if there was any statistical 
significant difference at baseline readings of ΔF between the lesions assigned 
to the four groups (Table 4-1). The results revealed that no statistical significant 
difference was detected (p >0.05). 
Table 4-1: One-way ANOVA between groups for ΔF values at baseline. 





Between Groups 44.16 3 14.72 .44 .72 
Within Groups 1715.39 52 32.98   





4.1.1.2 Difference in ΔF within each treatment group 
Table 4-2 shows the mean ΔF readings at start and end points. An 
improvement in ΔF values after treatment was seen across all groups except 
the negative control group (0 ppm F). 
Table 4-2: Mean values of ΔF at baseline and after treatment for all 
groups. 
Group Mean ΔF at 
baseline ± SD 
Mean ΔF after 
treatment ± SD 
Mean Difference in ΔF at 
baseline and after treatment ± 
SD 
0 ppm -17.82 ± 1.36 -20.04 ± 1.08 -2.214 ± 3.76 
1450 ppm -20.00 ± 1.56 -14.73 ± 0.89 5.275 ± 3.78 
Clinpro -18.49 ± 1.47 -16.06 ± 1.01 2.428 ± 4.16 
MI Paste Plus -19.71 ± 1.71 -14.88 ± 1.20 4.826 ± 5.14 
 
 




















ΔF Baseline and After treatment 




Paired T-Test was used to compare the mean ΔF at baseline and after 
treatment. The results show that in all groups except the negative control 
group, there was a statistical significant decrease in ΔF endpoint values 
compared with that at baseline (p <0.05) (Table 4-3). 
Table 4-3: Paired sampled T-Test results for ΔF values at baseline and 
after treatment. 



















2.21 3.76 1.00 0.04 4.38 .046* 
Clinpro 
 
-2.42 3.78 1.01 -4.61 -0.24 .032* 




-4.82 5.14 1.37 -7.79 -1.85 .004* 
 
* Statistically significant 
 
4.1.1.3  Difference in ΔF between all groups 
The following formula was applied to measure the difference in ΔF 
Difference in ΔF = mean ΔF after treatment – mean ΔF at baseline 
ΔF differences for all groups are shown in (Table 4.4) (Figure 4-3). Positive 
values were seen in all treatment groups except the negative control group (0 
ppm F). This indicated that there was an improvement in (ΔF) after treatment in 




of -2.21±3.76. The greatest improvement was shown in the 1450 ppm F group 
with a mean difference of 5.275± 4.165, followed by MI Paste Plus group with a 
mean of 4.83±5.14. A reduction in ΔF difference was also noticed in the Clinpro 
group with a mean of 2.43±3.78.  
 
Figure 4-3:  The mean difference in ΔF in the four groups. 
 
Table 4-4: Descriptive statistics for the difference in ΔF at baseline and 
after treatment for all groups. 
 
N Mean Std. 
Deviation 









14 2.21 3.76 0.04 4.38 -2.23 11.60 
Clinpro 
 




14 -5.27 4.16 -7.68 -2.87 -13.13 -0.20 
MI Paste 
 
























Mean Difference in ΔF




The following formula: was used to determine the percentage change in ΔF (% 
F): 
(Difference in ΔF at baseline and after treatment / ΔF at baseline) × 100 
It can be seen that both 1450 ppm F and MI Paste Plus groups had 
comparable values (26.33% and 24.48%) respectively. Lowest value (-12.41%) 
was detected in the negative control group (0 ppm F) as seen figure 4.4. 
 
































As the ΔF difference data were normally distributed, a parametric one-way 
ANOVA test was carried out to check whether the difference in ΔF was 
statistically significant between the four groups (Table 4-5). It showed that there 
was a statistical significant difference between the four groups (p <0.001). 
Table 4-5: One-way ANOVA between groups for the difference in ΔF from 
baseline. 












939.88 52 18.07   
Total 
 
1434.39 55    





Pairwise comparisons were applied using a Bonferroni test to identify which 
groups differed significantly. The results show that significant lower values were 
observed in the negative control group (0 ppm F) compared to the other groups 
(p < 0.05). However, the tests did not find any other statistical significant 
differences between the other groups (Table 4-6). 
Table 4-6: Multiple comparisons of the difference in ΔF at baseline and 
after treatment between all test groups and control. 
Pairwise Comparisons 




















-4.64* 1.60 .034 -9.05 -0.23 
NaF 2.84 1.60 0.49 -1.56 7.25 
MI Paste 2.39 1.60 0.85 -2.01 6.80 
 
0 ppm 
Clinpro 4.64* 1.60 0.03 0.23 9.05 
NaF 7.49* 1.60 0.00 3.08 11.89 




Clinpro -2.84 1.60 0.49 -7.25 1.56 
Free -7.49* 1.60 0.00 -11.89 -3.08 





Clinpro -2.39 1.60 0.85 -6.80 2.01 
Free -7.04* 1.60 0.00 -11.44 -2.63 
NaF 0.45 1.60 1.00 -3.95 4.85 
*. The mean difference is significant at the .05 level. 
 
4.1.1.4 Intra-examiner reproducibility for ΔF 
Nine slabs were randomly chosen for re-analysis. These represented 15% of 
the total slab number. The intra-examiner reproducibility was found to be 0.93 




4.1.2  ΔQ: Lesion volume  
 
4.1.2.1 Normality of ΔQ data 
Shapiro-Wilk and Kolmogorov-Smirnov tests were used to assess the data 
normality of ΔQ. The tests gave a P value of >0.05 which indicated that the 
data was normally distributed. 
One-way ANOVA test was performed to assess if there was any statistical 
significant difference at baseline readings of ΔQ between the lesions assigned 
to the four groups. The results revealed that no statistical significant difference 
was detected (p >0.05). 
4.1.2.2  Difference in ΔQ within each group 
Table 4-7. Shows the mean ΔQ readings at the start and after treatment. An 
improvement in ΔQ values after treatment was seen in all groups except the 





Table 4-7: The mean values of ΔQ at baseline and after treatment for all 
groups. 
Group 
Mean ΔQ at 





Mean Difference in ΔQ at 




























Figure 4-5: ΔQ mean values at baseline and endpoint for all groups. 
 
Paired T-Test was used to compare the mean ΔQ at baseline and after 
treatment. The results show that in all groups except the negative control group 
(0 ppm F), there was a statistical significant decrease in ΔQ values compared 




















ΔQ baseline and after treatment




























-2723.04 10187.03 2722.59 -3158.7 -8604.86 0.33 
Clinpro 11911. 8011.96 2141.28 -16537 -7285.07 0.00* 
1450ppm 13778. 10047.09 2685.2 -19579.1 -7977.07 0.00* 
MI Paste 
Plus 





* Statistically significant  
 
4.1.2.3  Difference in ΔQ between all groups 
The following formula was applied to measure the difference in ΔQ 
Difference in ΔQ = mean ΔQ after treatment – mean ΔQ at baseline 
ΔQ differences for all groups are shown in (Table 4.9) (Figure 4-6). Positive 
values were seen in all treatment groups except the negative control group (0 
ppm F). This indicated that there was an improvement in (ΔQ) after treatment in 
all groups except the negative control group with a mean difference of -
2723.04±10187.03. The greatest improvement was shown in the MI Paste Plus 




group with a mean of 13778.09±10047.09. A reduction in ΔQ difference was 
also noticed in the Clinpro group with a mean of 11911.04± 8011.96. 
 
Figure 4-6: Means of the difference in ΔQ at baseline and after treatment 
































Table 4-9: Descriptive statistics for the difference in ΔQ from baseline for 
all groups. 
 N Mean Std. 
Deviation 
95% Confidence Interval for 
Mean 
Minimum Maximum 




14 -2723.04 10187.03 -3158.77 -8604.86 -21570.66 20269 
Clinpro 
 
14 11911.04 8011.96 -16537.01 -7285.07 -30713 3578.33 
1450ppm 
 





15305.69 8792.48 -20382.31 -10229.06 
-31171.33 1244.67 
 
The following formula: was used to determine the percentage change in ΔQ (% 
Q) 
(Difference in ΔQ at baseline and after treatment / ΔQ at baseline) × 100 
Figure 4-7 shows the percentage for Q values. It can be seen that both 1450 
ppm F and MI Paste Plus groups had comparable percentages (66.75% and 
67.27%) respectively. Lowest percentage (-16.46%) was detected in the 





Figure 4-7: The % Q values for all groups. 
 
As the ΔQ difference data were normally distributed, a parametric one-way 
ANOVA test was carried out to check whether the difference in ΔQ was 
statistically significant between the four groups (Table 4-11). It showed that 
there was a statistical significant difference between the groups (p <0.001). 
Table 4-10: One-way ANOVA between groups for the difference in ΔQ at 
baseline and after treatment. 
ANOVA 











4500849650 52 86554800.96   
Total 
 




















Pairwise comparisons were applied using a Bonferroni test to identify which 
groups were differ significantly (Table 4-11). The results show that significantly 
lower values were observed in the negative control group (0 ppm F) compared 
to the other treatment groups (p < 0.05). However, the tests did not find any 
other statistical significant differences between the other treatment groups. 
Table 4-11: Multiple comparisons of the difference in ΔQ at baseline and 
after treatment between all test groups and control. 
Pairwise Comparisons 
(I) Groups (J) Groups Mean 
Difference (I-
J) 
Std. Error Sig. 95% Confidence Interval 
Lower Bound Upper Bound 
 
Clinpro 
Free -14634.09* 3516.38 0.001 -24279.37 -4988.81 
NaF 1867.04 3516.38 1.00 -7778.23 11512.32 
MI Paste 3394.64 3516.38 1.00 -6250.63 13039.92 
 
0 ppm  
Clinpro 14634.09* 3516.38 0.001 4988.81 24279.37 
NaF 16501.14* 3516.38 0.00 6855.86 26146.42 




Clinpro -1867.04 3516.38 1.00 -11512.326 7778.23 
Free -16501.14* 3516.38 0.00 -26146.42 -6855.86 





Clinpro -3394.64 3516.38 1.000 -13039.92 6250.63 
Free -18028.73* 3516.38 .000 -27674.01 -8383.45 
NaF -1527.59 3516.38 1.000 -11172.87 8117.68 






4.1.2.4 Intra-examiner reproducibility for ΔQ 
Nine slabs were randomly chosen for re-analysis. These represent 15% of the 
total slab number. The intra-examiner reproducibility found to be 0.96 which 






4.1.3 Area of the White spot lesion  
 
4.1.3.1 Normality of lesion area values 
Shapiro-Wilk and Kolmogorov-Smirnov tests were used to assess the data 
normality of lesion area. The tests gave a P value of <0.05 which indicated that 
the data was not normally distributed.  
Non-parametric Kruskal-Wallis test was performed to assess if there was any 
statistical significant difference at baseline readings of lesion area between the 
lesions assigned to the four groups. No statistical significant difference was 
detected between the four groups (p >0.05).  
4.1.3.2 Difference in lesion area within each group  
Table 4-12 shows the mean lesion area readings at the start and after 
treatment. A decrease in lesion area values after treatment was seen in all 
groups except the negative control group (0 ppm F). 
Table 4-12: The mean values of lesion area at baseline and after treatment 
for all groups. 
Group Mean ΔF at 
baseline ± SD 
Mean ΔF after 
treatment ± SD 
Mean Difference in ΔF at 
baseline and after treatment ± 
SD 
0 ppm 822.94±357 1011.09± 
368.19 
188.15 ± 394.60 
1450 ppm 1092.21± 
323.95 
441.23 ± 223.54 -636.69 ± 383.79 
Clinpro 1106.23± 
469.30 
520.78± 310.88 -585.45 ± 482.43 
MI Paste Plus 1249.23± 
481.36 







Figure 4-8: Lesion area at baseline and after treatment for all groups. 
 
A non-parametric test Wilcoxon’s matched pairs test was used to compare the 
mean lesion area at baseline and after treatment. The results show that in all 
groups except the negative control group (0 ppm F), there was a statistical 
significant decrease in lesion area values compared with that at baseline (p 






























Lesion area at baseline and after treatment




Table 4-13: Paired sampled T-test results for the lesion area values at 
baseline and after treatment for all groups. 




















-188.7 396.57 105.98 -417.71 40.23 0.09 
Clinpro 
 
-585.4 482.43 128.93 306.90 864 .001* 
1450 ppm -636.6 383.79 102.57 905.16 1279.9 .000* 
MI Paste 
Plus 
-761.4 285.58 76.32 971.30 1527.1 .000* 
 
* Statistically significant  
 
4.1.3.3 Difference in lesion area between all groups 
The following formula was applied to measure the difference in lesion area 
Difference in lesion area = mean lesion area after treatment – mean lesion 
area at baseline 
Lesion area differences for all groups are shown in table 4-14 and figure 4.9. 
Negative values were seen in all treatment groups except the control group (0 
ppm F). This indicated that there was a reduction in lesion area after treatment 
in all treatment group except the negative control group with a mean difference 
of -188.73± 396.57. The greatest reduction in lesion area was shown in the MI 
Paste Plus group with a mean difference of -761.4± 285.58 followed by 1450 
ppm F group with a mean of -636.6± 383.79. A reduction in lesion area was 





Figure 4-9: Means of the difference in the lesion area. 
 
Table 4-14: Descriptive statistics for the difference in the lesion area at 
baseline and after treatment for all groups. 
 N Mean Std. 
Deviation 
95% Confidence Interval for 
Mean 
Minimum Maximum 
Lower Bound Upper Bound 
0 ppm 
14 -188.73 396.57 -417.71 40.23 -760 744.33 
Clinpro 
14 -585.45 482.43 306.90 864 -252 1844 
1450ppm 
14 -636.6 383.79 905.16 1279.94 -136. 1129 
MI Paste 
Plus 










































The following formula: was used to determine the percentage change in lesion 
area (% Area) 
(Difference in lesion area at baseline and after treatment/lesion area at 
baseline) × 100 
Figure 4-10 shows the % change in the lesion area. It can be seen that both 
1450 ppm F and MI Paste Plus groups had comparable percentages (58.3.75% 
and 60.96%) respectively. Lowest percentage (-22.86%) was detected in the 
negative control group (0 ppm F). 
 





































As the lesion area difference data were normally distributed, a parametric one-
way ANOVA test was carried out to check whether the difference in lesion area 
was statistically significant between the four groups (Table 4-15). it showed that 
there was a statistical significant difference between the four groups (p <0.001).  
Table 4-15: One-way ANOVA between groups for lesion area values 
difference  
ANOVA 







7980995.69 3 2660331.69 16.99 .000 
Within Groups 8138582.65 52 156511..205   
Total 16119577.73 55    
 
 
Pairwise comparisons were applied using a Bonferroni test to identify which 
groups differed significantly (Table 4-16). The results showed that significant 
higher values were observed in the negative control group (0 ppm F) compared 
to the other groups (p < 0.05). However, the tests did not find any other 





Table 4-16: Multiple comparisons of the difference in area at baseline and 
















Free 783.47* 149.52 0.001* 373.32 1193.62 
NaF -51.23 149.52 1.00 -461.38 358.91 
MI Paste 175.97 149.52 1.00 -586.12 234.17 
 
0 ppm  
Clinpro -783.4762 149.52 0.00* -1193.62 -373.32 
NaF -834.71 149.52 0.00* -1244.86 -424.56 




Clinpro 51.23 149.52 1.00 -358.91 461.38 
Free 834.71 149.52 0.00* 424.56 1244.86 





Clinpro 175.97 149.52 1.00 -234.17 586.12 
Free 959.45 149.52 0.00* 549.30 1369.60 
NaF 124.73 149.52 1.00 -285.41 534.88 
*. The mean difference is significant at the .05 level. 
 
4.1.3.4 Intra-examiner reproducibility for lesion area 
Nine slabs were randomly chosen for re-analysis. These represent 15% of the 
total slab number. The intra-examiner reproducibility was found to be 0.97 





4.1.4 Summary of the results for all QLF three parameters 
(Remineralisation assessment) 
1- In all QLF parameters (ΔF, ΔQ, lesion area), there was an evidence of 
significant remineralisation in MI Paste Plus combined with fluoride 
toothpaste 1450 ppm F (0.32% w/w sodium fluoride) as a regimen, 
Clinpro tooth crème and fluoride toothpaste 1450 ppm F (0.32% w/w 
sodium fluoride) groups when compared with that at baseline as well as 
the control negative control group. 
 
2- There was no statistically significant difference in remineralisation 
between MI Paste Plus combined with fluoride toothpaste 1450 ppm F 
(0.32% w/w sodium fluoride) as a regimen,Clinpro tooth crème and 





4.2  Microhardness results 
In this study, enamel microhardness was assessed at baseline and after 21 
days by measuring the resistance to the penetration of the Knoop 
microhardness indenter. Five readings for each slab were carried out, and the 
mean readings for each slab were used.  
4.2.1  Test of normality of Indentation length 
In order to check the normality of indentation length data, the Shapiro-Wilk test 
was used. It can be seen from Table 4-17 that some of the values were 
normally distributed as they had P-value <0 .05. Therefore, a non-parametric 
test was used to analyse the data. 
Table 4-17: Tests of Normality (indent length - KMH). 
Groups Shapiro-Wilk  
Sig. 




Baseline   Clinpro 0.78 
Baseline 1450 NaF ppm 0.21 
Baseline MI Paste Plus 0.54 
Treatment 0ppm F 0.01* 
Treatment Clinpro 0.79 
Treatment 1450 NaF ppm 0.41 
Treatment MI Paste Plus 0.03* 
Mean Difference 0ppm F 0.20 
Mean Difference Clinpro 0.03* 
Mean Difference 1450 ppm NaF) 0.008* 





4.2.2 Difference in indentation length within the same group 
As the indentation length data were not normally distributed, non-parametric 
test Wilcoxon’s Matched pairs test was implemented to assess the differences 
within the same group at baseline and after treatment. The results of the test 
gave (p <0.001) values in all groups, which means that there was a statistical 
significant change after treatment when compared with baseline readings in all 
groups. Table 4.18 and figure 4-11 demonstrated the mean differences in 
indentation length at baseline and after treatment. The highest after treatment 
reading (indentation length) was seen in the negative control group (0 ppm) 
with 79.50 µm. However, all other groups had comparable post-treatment 
readings. 











 0 ppm F 68.36 3.87 79.50 11.35 11.3 9.39 0.001* 
Clinpro 68.65 3.60 72.50 5.22 3.85 3.82 0.001* 
1450 ppm NaF 68.05 3.38 71.6 2.84 3.01 2.21 0.005* 
MI Paste Plus 68.32 2.49 71.85 2.67 3.53 2.35 0.001* 







Figure 4-11:  indent length(µm) baseline and after (indent length created 
by Knoop microhardness indenter (KMH). 
 
 
4.2.3  Difference in Indent length between all groups 
The following formula was applied to measure the difference in indent length: 
Difference in indent length = indent length after treatment - indent length 
at baseline 
Descriptive statistics: 
Figure 4-12 illustrates the difference in Indent Length in the four tested groups. 
A positive difference in indentation length was found in all groups. This 
indicated that there was more enamel hardness loss after treatment in all 
groups compared to that at baseline.  
The highest increase in Indent Length was seen in the 0 ppm F with a mean 
























The effect of different formulations of toothpastes on enamel hardness 






values with the least increase was noticed in the 1450 ppm NaF group 3.01 ± 
2.21(Table 4-18). 
 
Figure 4-12: The effect of different formulations of toothpastes on enamel 
hardness (indent length created by indenter of MH) after cariogenic 
challenge. 
 
The following formula was applied to calculate the percentage of the changes 
in Indent Length (% IL) 
  
(Difference in IL at baseline and after treatment / IL at baseline) × 100 
Figure 4-13 demonstrates the % IL values for all groups. It can be seen that the 
greatest % IL difference value was found in the negative control group (0 ppm) 
with % IL of 16.53%, followed by that for Clinpro+ MI Paste Plus (5.6 and 5.1% 
































Figure 4-13: The % IL values for all groups. 
 
As the data were not normally distributed, a nonparametric test (Kruskal-Wallis 
Test) was carried out to assess if the difference in the enamel hardness (indent 
length - KMH) was statistically significant between the four groups. It indicated 
that the mean difference in enamel hardness was statistically significant 
between the groups (p <0.05). 
To identify which groups were statistically significant different, Kruskal-Wallis 
test with pairswise comparisons, p<0.05 was performed (Table 4-19). The 
results revealed that the mean change in (indent length) was statistically 
significantly different in the negative control group (0 ppm F) when compared to 
other groups. However, the tests did not find any other statistical significant 






































Table 4-19: Comparison between different formulations of toothpastes on 
the hardness of enamel using the length of the indent (Mean 
Difference) created by KMH. 
*Significant. Kruskal-Walis test with pairs wise comparisons, p<0.05.  
 
4.2.4 Intra-examiner reproducibility for indentation length 
Nine slabs were randomly chosen for re-analysis. These represent 15% of the 
total slab number. The intra-examiner reproducibility was found to be 0.98 
which indicates an excellent reproducibility. 
  







0 ppm F vs MI Paste Plus 
 
 
7.77 6.16 0.019* 
0 ppm F vs 1450 ppm NaF 8.29 6.16 0.015* 
0 ppm F vs Clinpro 7.45 6.16 0.011* 
MI Paste Plus vs 1450 NaF ppm F 0.52 6.16 .935 
MI Paste Plus vs Clinpro -0.32 6.16 0.853 




4.2.5 Summary of the Microhardness results (Demineralisation 
assessment) 
1- In all groups, there was an evidence of enamel hardness loss compared 
to that at baseline. 
 
2- There was evidence of significant enamel hardness loss in the negative 
control group (0 ppm F) after treatment when compared with the other 
groups.  
 
3- There was no significant statistical difference in the efficacy to inhibit 
enamel demineralisation between MI Paste Plus combined with fluoride 
toothpaste 1450 ppm F (0.32% w/w sodium fluoride) as a regimen, 








The effects of several preventive agents like CPP-ACP and f-TCP have been 
investigated but there is still considerable controversy surrounding the use of 
these products over the use of fluoride products alone. These newer agents are 
more expensive than conventional F products and it is important that they are 
shown to be efficacious, provide an additional benefit over F toothpaste alone, 
and are cost-effective to use. Few in situ studies have investigated the ability of 
these products to inhibit enamel demineralisation and enhance enamel 
remineralisation. Moreover, to the best our knowledge QLF has never been 
reported to have been used to assess enamel de/remineralisation in situ.  Also, 
previous studies mainly investigate the effect of the agents on their own, 
despite the fact that some are used in addition to daily use of fluoride 
toothpaste.  It is important to study the efficacy of these agents that are 
prescribed for daily use in the way that they are used routinely. 
Therefore, the aim of this work was to compare the efficacy of MI Paste Plus 
combined with fluoride toothpaste 1450 ppm F (0.32% w/w sodium fluoride) as 
a regimen, with f-TCF Clinpro tooth crème 950 ppm F (0.32% w/w sodium 
fluoride) and fluoride toothpaste 1450 ppm F (0.32% w/w sodium fluoride), on 
remineralisation of the enamel subsurface caries-like lesion in an in situ 





5.1 In situ model 
The ability of the test products to inhibit enamel demineralisation and enhance 
remineralisation was investigated using an in situ model in the present study. 
The in situ model used in this study has been widely used in dental research as 
it has several advantages over the other models. The main advantage is that it 
has the ability to allow the investigation to take place in the oral environment. 
Another advantage is that it is less time consuming and provides more control 
over the experimental variables compared to clinical trials (Zero, 1995). 
 In situ models also have several limitations. The main disadvantage is that the 
sample size is usually small due to the nature of and complexity of the model 
and care should be exercised while extrapolating the results to the wider 
population.  Also, the in situ model is highly reliant on participants’ compliance, 
requiring the participation of highly motivated participants (Zero, 1995). 
In the present in situ study, written and verbal instructions were given to the 
participants at every visit. A dipping diary was also used to help volunteers 
comply with the study protocol. Also, the toothbrushes and toothpastes were 
checked after each study arm to assess the compliance with the study protocol. 
5.2 Study design  
Two main designs are used for in situ studies, cross-over and parallel designs. 
The present in situ model used the cross-over design. The cross-over approach 
offers several benefits. The foremost advantage is that it requires less sample 




participant as their own control. However, this also means that care has to be 
exercised to reduce the risk of having a residual effect which may affect the 
results. To reduce the carryover effect, a wash period between the arms is 
required (Zero,1995; Stephen et al. 1992). In this present study design, a 
cross-over method was used with a minimum of seven days wash-out period 
between study arms. In addition, all participants had a wash-in period of one 
week to minimise any residual effect of the previous toothpastes they used to 
have before starting the study. Seven days wash-out period has been used in 
several in situ studies (Zero,1995; Stephen et al. 1992). 
5.3 Sample size  
The sample size was calculated following statistical advice. The sample size 
was carried out using data from previous in vivo study by  Manal Allammari et 
al. (2010) to detect a difference of 5% in ΔF between four materials with an 
estimated standard deviation of 4.5% and with a significance level (alpha) of 
0.05. Based on these values, a sample size of 12 participants was required. 
However, 14 participants were recruited to ensure the completeness of the 





5.4 Standardisation  
Standardisation is an essential factor when designing in situ studies and indeed 
any clinical study as this would minimise variations between subjects (Zero, 
1995). 
In the present study, standardisation was achieved by several means. During 
subject recruitment, specified inclusion and exclusion criteria were applied 
according to the recommendation by Curzon and Hefferren, (2001). 
Standardisation was also achieved in the present model by asking participants 
to use only the assigned toothpaste for each arm. No other fluoride-containing 
food or products were used during the study. Other factors like saliva and 





5.5 Hard tissue substrates  
Several types of hard tissue substrates can be used in caries research. Human 
enamel is considered the substrates of choice (Curzon and Hefferren, 2001). 
However, several disadvantages limit its use. Human enamel is difficult to 
obtain in a large quantity and good quality. In addition, human teeth associated 
with great variations in their compositions and response as they are usually 
obtained from different sources. Moreover, a large flat enamel surface is rarely 
found as most of the human teeth used are posterior teeth (Zero, 1995; 
Mellberg, 1992). 
Enamel slabs that used in the present study were obtained from bovine incisors 
as it was difficult to obtain human enamel in a large number. Bovine enamel 
has been commonly used as an alternative to human teeth over the past years 
(Hollanders et al., 2018; Yassen et al., 2011). The key advantage of using 
bovine teeth is that it is relatively easy to obtain a large number of teeth in 
sound quality. Furthermore, unlike human teeth, bovine teeth have less 
variability in their composition and response. Also, a large and flat intact 
enamel can be simply obtained (Sønju Clasen and ØGaard, 1999; Zero, 1995; 
Mellberg, 1992). 
On the other hand, the caries progression in bovine enamel is faster than 
human teeth as it has more porous enamel. Also, the chemical and mechanical 
structures of bovine teeth are not the same as the human teeth (Sønju Clasen 




use of bovine enamel as an alternative to human enamel for caries research is 
acceptable (Zero, 1995; Mellberg, 1992).  
Prior to the use of bovine teeth, the possible occurrence of an infectious 
disease called bovine spongiform encephalopathy (BSE), or mad cow disease 
was considered. This disease attacks bovines and produces a progressive 
neurodegenerative lesion, by means of an infectious prion (Prusiner, 1982). In 
order to eliminate prions, the slabs were immersed in 12% sodium hypochlorite 
for 24 hours. It has been shown that sodium hypochlorite did not have an effect 
on the mineral content of dentine or its crystal structure (Driscoll et al., 2002). 
5.6 Artificial caries lesion  
In caries research, enamel subsurface caries-like lesion is commonly used to 
mimic the white spot lesions in the natural environment. Two main methods are 
mainly used to create artificial lesions; chemical and oral microbiota models. 
Both models produce a relatively similar amount of enamel demineralisation. 
(Abufarwa et al., 2018). 
Two methods can be used to create enamel subsurface like lesion using the 
chemical model; buffered solutions or acidified gels. In the present model, 
artificial lesions were created using an acidified gel chemical model as 
described earlier in section 2.4.3. This model has been used in several studies 
and produced consistent enamel lesions. In addition, the acidified gel is easy to 





5.7 Intra-oral appliance design  
In the present study, a lower removable appliance with two buccal acrylic 
flanges was used. This design was introduced by (Koulourides et al., 1974). 
Two enamel slabs were inserted into the acrylic flanges and secured with wax. 
This was then covered with mesh to accumulate dental plaque. The slabs were 
placed buccally to protect the slabs and biofilm from the tongue movement and 
minimise disturbance. To ensure standardisation, slabs were placed in the left 
side for all participants’ appliances.  
This design has a number of advantages. Several in situ studies have used this 
design without causing damage to the oral structure or causing discomfort. It 
also allows for normal daily oral hygiene as it is easy to remove during brushing 
as well as during eating and drinking (Malinowski et al., 2018). However, the 
removable appliances have some disadvantages, such as the issue of having 
bulky acrylic appliances that might cause discomfort for the participants. In 
addition, the removable appliances might cause mucosal damage or dental 
caries secondary to plaque accumulation. To overcome these limitations, we 
were regularly monitoring the participants’ oral health during the study. The 
participants were clinically examined during each visit. In addition, the 
participants were instructed to return to the study site if they experienced any 
discomfort for the appliance to be adjusted.  
Our patient information sheet lacked some information about the potential 




consider reviewing the patient information sheet and explaining all the potential 
disadvantages of wearing the appliances.  
5.8 Use of Quantitative Light-induced Fluorescence (QLF) 
QLF is a quantitative system to detect early lesion as well as measuring 
enamel remineralisation based on the concept that the change in mineral 
content of tissue affects its autofluorescence. The key benefit of QLF system is 
that it is a non-destructive method to assess the enamel de/remineralisation. 
This advantage allows for easy conduction of longitudinal evaluation of the 
lesions (Karlsson, 2010). Also, QLF has been validated against the gold 
standard TMR with a statistically positive correlation (r = 0.63) (Cochrane et al., 
2012). Moreover, excellent intra-examiner and inter-examiner reproducibly 
were found in several in vitro and in vivo studies (Bataineh et al., 2017; Al-
Khateeb et al., 2002; Pretty et al., 2002; Tranæus et al., 2002). In the current 
study the intra-class correlation for the intra-examiner coefficient was found to 
be (0.96) which represented an excellent reproducibly. 
However, QLF’s readings can be affected by several confounders (Al-Khateeb 
et al., 2002). Therefore, the study images were captured in a standardised and 
controlled environment. These were achieved by using the same camera 
position, angels and distance. In addition, the slabs were dried for 15 seconds 
to minimise the hydration effect as recommended by (Al-Khateeb et al., 2002). 
To reduce the light effect, pictures were taken and analysed in a dark room. 




consistency. The operator (MA) had received training by the manufacturer 
before the use of QLF. 
In this in situ study, three parameters were assessed; ΔF which represents the 
percentage fluorescence loss and is related to lesion depth, the lesion surface 
area and lesion volume (ΔQ). However, (ΔQ) was considered as the main 
parameter in the present study. Ando et al. (2004) concluded in their study that 
ΔF and lesion area may not correlate. This means that the lesion area may not 
change while the ΔF changes or instead the lesion area may sustain while 
there are changes in ΔF. Therefore, it was recommended to use (ΔQ) as the 
primary parameter when assessing lesion progression or regression. 
 
5.9 Use of Microhardness 
One of the methods that were used to assess demineralisation and 
remineralisation is microhardness. This system measures the resistance of the 
enamel structure to the force applied by the indenter. As discussed earlier in 
section 1.4.1, the microhardness testing is classified into surface 
microhardness (SMH) and cross-sectional microhardness (CSMH) (White et 
al., 1992; Arends and Ten Bosch, 1992). In the present study, Knoop SMH was 
used to assess the ability of test products to inhibit enamel demineralisation. 
The use of SMH has several benefits. It is non-destructive and easy to use. 
Also, it is sensitive to mineral change (Arends and Ten Bosch, 1992; Zero et 




standard TMR, and a significant positive correlation was found (Lippert and 
Lynch, 2014). 
However, the main drawback is that SMH is less sensitive to assess deep 
lesions. Another disadvantage is that it does not give much details about 
mineral distribution and lesion shape (Arends and Ten Bosch, 1992; Zero et al., 
1990). 
Several loads have been used ranging from 50g up to 500g for caries research. 
A 100g load using the Knoop diamond was applied in this study. This load was 





5.10 Remineralisation potential of the test products on 
artificial subsurface like lesions using QLF  
The first part of this in situ study was conducted to assess and compare the 
remineralisation ability of three different products; 1450 ppm NaF, Clinpro tooth 
crème and a combination of MI Paste Plus with 1450 ppm NaF as a regimen 
using QLF. The 0 ppm F toothpaste was used as a negative control group. 
Artificial lesions were created and assessed at baseline and after treatment 
under controlled conditions using QLF. 
The results showed that there was a statistically significant improvement in 
remineralisation in all groups except the negative control group compared with 
that at baseline in all QLF parameters. Whereas, the negative control group 
showed significant lesion progression in all QLF parameters. This was 
expected due to the lack of fluoride in the negative control group and the use of 
intense cariogenic challenge (five dipping a day in a sugary solution for 2 
minutes during the whole arm). 
The highest (ΔQ) improvement was seen in the regimen group (MI Paste 
Plus+1450 ppm NaF. However, multiple comparison tests with Bonferroni 
correction did not find any statistically significant differences between MI Paste 
Plus with 1450 ppm NaF as a regimen compared with1450 ppm NaF and 




5.10.1  Effect of CPP-ACPF + 1450 ppm NaF as a regimen  
The ability of CPP-ACP products to enhance enamel remineralisation has been 
shown in several in vitro and clinical studies (Reynolds, 2009). A recent 
systematic review concluded that CPP-ACP had a significant long-term 
remineralisation ability when compared with placebo (Li et al., 2014).  
Moreover, the synergic effect of CPP-ACP and fluoride has been demonstrated 
in multiple studies (Mendes et al., 2018; Tao et al., 2018; Altenburger et al., 
2010; Reynolds et al., 2008). The synergic effect is thought to be due to the 
formation of CPP-stabilised amorphous calcium fluoride phosphate. (CPP-
ACFP).  
The present findings agreed with the previous studies as the regimen group 
(CPP-ACPF + 1450 ppm NaF) showed significant remineralisation 
improvement compared with that at the baseline as well as the negative control 
group.    
5.10.2  The benefits of using CPP-ACFP as a regimen with fluoride 
over the use of fluoride products alone 
The benefits of using CPP-ACFP as a regimen with fluoride over the use of 
fluoride products have been investigated in the literature. However, there is still 
much controversy surrounding the benefits of this approach over conventional 
use of fluoride products alone.  
Although the results demonstrated a trend towards more enamel 
remineralisation in the regimen group (CPP-ACPF + 1450 ppm NaF), our 




regimen with 1450 ppm NaF over the use of 1450 ppm F alone. These findings 
were in agreement with several in vitro and in situ studies (Bataineh et al., 
2017; Vyavhare et al., 2015; Huang et al., 2013; Sitthisettapong et al., 2012; 
Bröchner et al., 2011; Beerens et al., 2010). However, the current study 
conflicts the findings published by Mendes et al.(2018) who compared the 
remineralisation ability of four different products (Placebo, 1.23% acidulated 
phosphate fluoride, MI Paste™ and MI Paste Plus Plus™) in vivo. The study 
participants were using routine dental care (1450 ppm F) in all groups. The 
study found a significant lesion regression with MI Paste™ and MI Paste Plus 
Plus™ at 90 days compared to other groups. However, the enamel regression 
was only significant after 30 days. Furthermore, our findings are not in 
agreement with the  results demonstrated by Reynolds et al. (2008) who 
conducted a randomised, double-blind cross-over in situ study to assess the 
enamel remineralisation ability of different toothpaste slurries; (i) placebo, (ii) 
1100 ppm NaF, (iii) 2800 ppm NaF, (iv) 2% CPP-ACP and (v) 2% CPP-ACP 
Plus 1100 ppm NaF. The study concluded that CPP-ACP Plus 1100 ppm NaF 
as a regimen showed significant more remineralisation compared with the other 
groups, over two weeks. In this study the application of the experimental pastes 
was not followed according to the manufacturer recommendations. 
In the present study, the MI Paste+1450 ppm F regimen could be expected to 
have more significant remineralisation efficacy compared with other 
experimental pastes due to the presence of higher concentration of fluoride. 
However, this was not the case.  There are several possible explanations for 




duration was 21 days per study arm. Several studies have reported significant 
remineralisation effect with a longer period of exposure (Mendes et al., 2018; 
Hegde and Moany, 2012). Another possible reason could be the application 
sequence of the pastes. In the present in situ study , the MI Paste Plus was 
applied immediately after the use of fluoridated toothpaste (1450 ppm NaF). 
Therefore, the formation of fluorapatite ions might block the enamel pores 
preventing the diffusion of calcium and phosphate ions. A recent in vitro study 
tested the different application sequence of CPP-ACFP and fluoride and 
concluded that the application of CPP-ACFP before the fluoride therapy 
provides the optimum remineralisation results (Al-Batayneh et al., 2017).  





5.10.3 Comparison of remineralisation ability of CPP-ACFP and 
Clinpro Tooth Crème 
Few clinical studies have directly compared the remineralisation potential of 
CPP-ACFP and f-TCP Clinpro tooth crème. In the present in situ study, the 
participants were instructed to use these products as per manufacturer 
directions.  
In both groups, the present study found significant remineralisation in all QLF 
parameters compared with that at the baseline as well as the negative control 
group. However, the study failed to find any significant difference between them 
when compared to each other.  
The findings of the current study are consistent with a randomised controlled in 
situ study that was published by (Vanichvatana and Auychai, 2013). In their 
study, the remineralisation ability of CPP-ACFP and Clinpro tooth crème were 
compared with fluoridated toothpaste (1450 ppm F). The study found that all 
the test products produced significant remineralisation. However, no significant 
difference was detected between the groups. The previous findings were also 
in agreement with other  in vitro studies (Jo et al., 2014; Joshi et al., 2013). 
In contrast with previous findings, Shen et al. (2011) conducted a randomised 
controlled trial and reported higher significant remineralisation in CPP-ACP and 
CPP-ACFP groups when compared with Clinpro tooth crème and different 
concentrations of fluoridated toothpaste. However, a shortcoming of the 
previously mentioned study was it lacked any sample size calculation. 




application CPP-ACP and CPP-ACFP products were not following the 
manufacturers’ recommendations. 
5.11 The ability of the test products to inhibit enamel 
demineralisation using microhardness  
In this part of the study, the inhibitory effect on demineralisation of three 
different products; 1450 ppm NaF, Clinpro tooth crème and a combination of MI 
Paste Plus with 1450 ppm NaF as a regimen was assessed using 
microhardness test in situ. The non-fluoridated toothpaste was used as a 
negative control group. Intact bovine enamel slabs were assessed at baseline 
and after 21 days of intensive cariogenic challenge (five dipping a day using 
12% sucrose, two minutes for each dipping). The use of sound enamel slabs is 
the preferable approach to assess enamel demineralisation and lesion 
formation (Mellberg, 1992). 
It was evident that there was an enamel hardness loss in all groups compared 
to the values at baseline. The highest enamel hardness loss was seen in the 
negative control group (0 ppm F). This finding was expected due to the 
intensive cariogenic challenge and the lack of fluoride in the negative control 
group. 
The statistical tests revealed that there was a statistically significant difference 
in term of enamel hardness loss between the negative control group and the 
other test groups. However, no significant differences were detected between 
the other groups. This means that significant enamel demineralisation was 




The effect of the CPP-ACP and CPP-ACFP agents in inhibiting enamel 
demineralisation has been well reported in the literature. This is believed to be 
due to the ability to stabilise and localise ACP on the tooth surface as well as 
on the plaque (Reynolds 2009; Reynolds, 2008). Our findings correlate 
favourably with several studies that showed a significant effect of reducing  
enamel demineralisation when using CPP-ACP and CPP-ACFP agents 
(Bröchner et al., 2011; Robertson et al., 2011; Uysal et al., 2010). 
The ability of f-TCP Clinpro tooth crème to inhibit enamel demineralisation was 
also investigated in this part of the study. The results revealed a significant 
impact on inhibiting enamel demineralisation when compared with the negative 
control group, this finding is in agreement with studies published previously (Jo 
et al., 2014; Vanichvatana and Auychai, 2013). 
When comparing the test product with each other, the statistical analysis did 
not find any significant difference in their efficacy. It would have been 
reasonable to have expected the regimen group to have a higher efficacy due 
to the presence of a high concentration of fluoride. A positive correlation has 
been reported between the fluoride dose and effect on  preventing enamel 
demineralisation and enhancing remineralisation (Marinho et al., 2016; Walsh 
et al., 2010). The reason for this contradictory result is not entirely clear, but 
there are several possible explanations. It could be the application order as 
described earlier. CPP-ACP and CPP-ACFP behave better when applied 
before the application of the fluoridated toothpaste (Al-Batayneh et al., 2017). 
In this study, CPP-ACFP was applied immediately after the application of the 




In our protocol, the period of each arm was 21 days. CPP-ACP and CPP-ACFP 
have been reported to produce a significant inhibitory effect with more 
extended periods (Mendes et al., 2018; Hegde and Moany, 2012). 
Another possible speculation which is supported by limited evidence is the time 
of CPP-ACFP application in relation to the cariogenic challenge. CPP-ACFP 
and CPP-ACP have been shown to work better when applied 10 minutes 
before the cariogenic challenge (Yamaguchi et al., 2007; Yamaguchi et al., 
2006). In our model, the CPP-ACFP was applied after the cariogenic challenge.  
5.12 Remineralising potential of f-TCP technologies 
Interestingly, the results of our study found that the ability of f-TCP Clinpro 
crème to enhance enamel remineralisation and inhibit enamel demineralisation 
did not differ statistically than 1450 ppm F and CPP-ACFP regimen. It should 
be emphasised that f-TCP Clinpro crème has less fluoride concentration that 
1450 ppm and CPP-ACFP regimen groups. Therefore, f-TCP Clinpro crème 
may be of benefit for patients at high caries and at risk of developing fluorosis 
such as children under age of three years old. 
The results indicate that f-TCP can be a promising technology to enhance 
enamel remineralisation and inhibit demineralisation of the enamel. However, 




5.13 Suggestion for future research  
The results of current in situ study, have been promising in term of the ability of 
f-TCP Clinpro tooth crème (950 ppm F) to enhance remineralisation and 
inhibiting demineralisation of enamel. The current literature does not provide 
sufficient evidence to support this. Future well-conducted randomised clinical 
studies on this topic are therefore required to confirm these findings.  
The results of this study did not find any significant difference of using MI Paste 
Plus combined with fluoride toothpaste 1450 ppm F (0.32% w/w sodium 
fluoride) as a regimen over the use of routine fluoridated toothpaste (1450 ppm 
F). We suggest further research to investigate the effect of using different 
application sequence than the one we used. In addition, further well-conducted 





5.14 Null hypotheses outcome  
1. The nul hypothesis “ There is no difference between 0 ppm F toothpaste; MI 
Paste Plus combined with fluoride toothpaste 1450 ppm F (0.32% w/w sodium 
fluoride); Clinpro tooth crème 950 ppm F (0.21% w/w sodium fluoride) and 
fluoride toothpaste 1450 ppm F (0.32% w/w sodium fluoride), on 
progression/regression of artificial subsurface carious lesions in situ as 
measured by QLF” can be rejected as significant differences were detected in 
the enamel remineralisation between 0 ppm toothpaste and all other tested 
products. 
2. The null hypothesis “There is no difference in the effect of different caries 
preventive regimen and therapies: MI Paste Plus combined with fluoride 
toothpaste 1450 ppm F (0.32% w/w sodium fluoride); Clinpro tooth crème 950 
ppm F (0.21% w/w sodium fluoride) and fluoride toothpaste 1450 ppm F (0.32% 
w/w sodium fluoride), on progression/regression of artificial subsurface carious 
lesions in situ as measured by QLF” can be accepted as no significant 







3. The null hypothesis “There is no difference between 0 ppm F toothpaste; MI 
Paste Plus combined with fluoride toothpaste 1450 ppm F (0.32% w/w sodium 
fluoride); Clinpro tooth crème 950 ppm F (0.21% w/w sodium fluoride) and 
fluoride toothpaste 1450 ppm F (0.32% w/w sodium fluoride), on the inhibition 
of the demineralisation process in dental enamel under cariogenic challenge in 
situ as measured by SMH” can be rejected as significant differences were 
detected in the enamel demineralisation between 0 ppm group and all other  
tested products. 
 
4. The null hypothesis “There is no difference in the effect of a different caries 
preventive regimen and therapies: MI Paste Plus combined with fluoride 
toothpaste 1450 ppm F (0.32% w/w sodium fluoride); Clinpro tooth crème 950 
ppm F (0.21% w/w sodium fluoride) and fluoride toothpaste 1450 ppm F (0.32% 
w/w sodium fluoride) on the inhibition of the demineralisation process in dental 
enamel under cariogenic challenge in situ as measured by SMH” can be 
accepted as no significant differences were detected in the enamel 







From the results of this study it can be concluded that: 
1- 1450 ppm NaF toothpaste was as effective as calcium phosphate 
delivery technologies in remineralising enamel subsurface lesions and 
inhibiting enamel demineralisation. Within the limitations of this study, it 
seems appropriate that dentists should advise patients to use 
conventional fluoride 1450 ppm especially in term of cost effectiveness. 
2-  QLF was shown to be able to assess enamel de/remineralisation in our 
in situ model. QLF offers significant advantages include being non-
destructive and time saving. However, standardised and controlled 
environment are required to minimise the effect of the confounders such 
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Appendix 1: Ethical approval from the Dental Research 








Appendix 2: Advertisement poster of the study 
 
Version 3   05th September 2016 
 
 
                                           
                                                              
 
 
                                 Are you aged 18-65? 
 
                    Are you fit and healthy? 
 
Would you be interested in participating in a 
research study? 
 
We are studying the effect of using a different preventive 
toothpastes for prevention of enamel demineralization 
(weakening). 
 
What we will need from you is to wear an oral appliance, and to 
keep the appliance in a sugar solution and in slurries of 
toothpastes (which we will provide) on certain times during the day  
 
You will receive £100 for each completed phase for taking 
part in the study as a compensation for your time and 
inconvenience 
 
For further information, please contact Mannaa Aldowsari, 
School of Dentistry - University of Leeds 




























Appendix 4: Patient information sheet 
 
Volunteer Information Sheet 
 
Thank you for expressing an interest in our forthcoming study. Please find below 
some more information about the study, which we hope will answer some of the 
questions you may have. 
 
Version 4, Dated 05/09/2016 
 
Study Title: “The Use of Caries Preventive Agents Alone and In Regimen 
for Prevention of Enamel Demineralisation Under Cariogenic Challenge In 
situ”  
 
“The Effect of Using A Different Preventive Toothpastes For Prevention of 
Enamel Demineralization (Weakening) Under Sugary Challenge.” 
 
 
Ethics Committee Ref No:  140616/MA/205  
 
 
You are being invited to take part in the above research study. Before you decide, 
it is important for you to understand why the research is being done and what it 
will involve.  Please take time to read the following information carefully, and 
discuss it with others if you wish. Ask us if there is anything that is not clear, or if 
you would like more information.  Take time to decide whether or not you wish to 
take part.   
 
What is the purpose of the study? 
This study is part of my Professional Doctorate in Paediatric Dentistry Degree. 
The aim of this project is to study the effect of using additional preventive 
toothpastes, over and above the daily use of the conventional fluoride toothpaste 
for prevention of enamel demineralization (weakening). 
 
Why have I been chosen? 
We hope to recruit volunteers for this study. All we ask of volunteers is that they 
are willing to take part in the study; that they are at least 18 to 65 years old; that 
they are in general good health; that they are not pregnant or planning to become 




stability of the oral environment (even though pregnant women are excluded, 
should you become pregnant whilst in the study there is no significant risk to the 
baby, but please let us know immediately); and that they have at least 18 natural 
teeth. Before you are enrolled on the study, you will need to be ‘screened’. This 
will involve a short dental examination, to enable us to establish whether you 
meet all our criteria and a professional scaling and polishing if there is any tartar. 
We will also ask you a few simple questions about your general health, this 
information is kept confidential. You will also have the opportunity to ask us any 
questions you may have about the study. 
 
Do I have to take part? 
Participation in this study is entirely voluntary. If you decide you would like to 
take part, you will be given a copy of this information sheet to keep, and we will 
ask you to complete and sign a form which gives your written consent to take 
part. If after reading this and thinking about the information given, you decide you 
would not like to take part that is fine. Even if you decide you would like to take 
part in the study, but you later decide you no longer wish to continue, you can 
withdraw at any time, and you do not have to give us a reason unless you want 
to. If you do decide to withdraw from the study at any point, please let us reassure 
you that your future dental care at the Dental Hospital will in no way be 
compromised. If you are a member of staff of the Trust or University, you are 
under no obligation whatsoever to take part in this study, but if you decide you 
would like to take part, you can still withdraw at any point without having to give 
a reason.   
 
What will happen to me if I take part? 
If you decide you would like to take part and our screening procedures identify 
you as a suitable volunteer, then we have to have your written consent in order 
to recruit you. You do not have to give consent on the day of the dental 
examination, but you will have one week to decide.  
 
At the first appointment we will collect a sample of saliva by asking you to spit in 
a tube for 2 minutes. You will also be asked to use fluoride-free toothpaste for 1 
week before each sampling appointment. A lower dental impression using 
alginate impression will be taken to construct a removable appliance for your 
lower teeth . You will wear this removable appliance which contains two sterilised 
bovine enamel chips. These sections are the parts that we will do our test on. It 
will be given to you before each part of the study and should be worn at all times, 
except at mealtimes, drinking, toothbrushing, and dipping time.  You will also be 
asked to keep the appliance in solutions of sucrose and in slurries of toothpastes 
on certain times during the day which we will provide. You will be provided with 
fluoride-free toothpaste in each part of the study, which you will use twice daily 
to brush your teeth normally for 7 days between the study phases and on one of 
the study phases for 21 days. 
 
We will show you how to remove and re-insert the appliance, and you will have 
opportunity to ask any questions, and to make sure you are happy and confident 





The study consists of 4 periods. The duration of each experimental period will be 
one month making a total of four months for the whole study.   
 
You will need to visit us two times in each period. These visits are to provide you 
with the appliance and collect it from you at the end of each study period. The 
appliance will be collected by the researcher (Mr.Mannaa Aldowsari), and the 
enamel pieces will be removed in the laboratory. 
 
Once you decide to take part in the study, you will be given an appointment card 
showing the days and times we would like you to attend our test centre at the 
Leeds Dental Institute. You will have opportunity to ask any questions, and to 
make sure you are happy and confident before starting the study. 
 
What do I have to do? 
You will need to agree to have the appliances in your mouth, and to agree to 
remove the device when eating and/or drinking and at toothbrushing time. You 
will also need to come into the test centre at the dates and times agreed. We 
realise that this may cause you some inconvenience. In recognition of any 
inconvenience and out of pocket expenses you will incur, you will be paid a fee 
of £100 per each period for taking part in the study which will be paid at the end 
of the last period.  
 
 
What are the side effects of taking part? 
We hope there will be no side effects for volunteers. You as volunteer may have 
a small amount of discomfort from the appliance which usually occurs during the 
first couple of days. However in previous studies where the same appliance has 
been used, volunteers became used to it after a couple of days. If there is any 
pain, discomfort, or any other problems with the appliance at home (e.g. 
accidentally broken) please contact us on the telephone number 07843925822 
(Mr. Mannaa Aldowsari -Researcher) and we will arrange an appointment to 
adjust the appliance if needed 
 
The other slight risk to you as a volunteer would be a very small chance of 
enamel demineralisation, because you will be using fluoride-free toothpaste 
during the study. However, previous tests have shown that teeth regain lost 
minerals naturally by saliva. As an extra precaution, you will have a topical 
fluoride gel professionally applied at the end of the study.   
 
We are confident that no damage will be caused to you or your teeth if you take 
part in this study. 
 
What are the possible disadvantages or risks of taking part? 
The only disadvantage to you as a volunteer will be that you will be asked to 
wear and remove the device at the times specified. For the first few days of the 




routine of working with the appliance, we are sure you will find it easy to 
remember what to do and when. 
 
What are the possible benefits of taking part? 
There is no direct immediate benefit to the research participants. However, part
icipants will help us to study the effect of additional preventive therapeutic aids, 
over and above the daily use of a fluoride toothpaste for prevention of enamel 
demineralisation. 
 
What if new information becomes available? 
If any new information becomes available during the study, we will of course let 
you know as soon as possible, and explain the changes to you. You will have 
the chance to ask us any questions before deciding whether you would like to 
continue with the study. If the changes are significant, it may be that we ask for 
your written consent to continue with the study.  Please let us stress that, should 
this occur, you will be under no obligation whatsoever to continue with the study, 
and you may still withdraw at any point without giving a reason. 
 
What happens when the research study stops? 
At the end of the study, you will need to come back to the test centre. A dentist 
will remove the device; give you a final check up and a professional tooth 
cleaning. We will then collect all our data, and examine it in our laboratory. Once 
this is done, we will write a report on our findings. We will not identify any of our 
volunteers by name in our report.  Any information we collect about you during 
our study will be kept strictly confidential.   
 
Is this research part of your university studies? 
Yes, I will submit the results of this study as my research thesis to fulfil the 
research component of my 
Professional Doctorate in Paediatric Dentistry degree.  I would like to thank you 
for helping me complete this research. 
 
What if something goes wrong? 
If you have any concerns about your treatment during the study, please do not 
hesitate to contact any one of us, and we will do our best to help. 
If you feel that the matter is serious, it may be that you will be entitled to 
appropriate compensation, from the sponsor of the study (University of Leeds). 
The sponsor, without armal commitment should compensate you without having 
to prove that it is at fault. This applies in cases where it is likely that such injury 
has resulted from any new drugs or procedures carried out in accordance with 
the protocol of the study. The sponsor “will not compensate you where such 
injury results from any procedure which is not in accordance with the protocol for 
the study”. Your right to claim compensation for the injury where you can prove 
negligence is not affected. 
 In the very unlikely event of you being harmed as a result of taking part in the 
study no special indemnity arrangements are in place. Your right at law to claim 





Will my taking part in this study be kept confidential? 
If you consent to take part in this study, any information we gather will be kept 
confidential. You will not be identified by name in any reports or publications.  
 
What will happen to the results of the research study? 
We will report on the results of this study as a research thesis for a higher 
degree. We hope to publish the results in an international journal and present 
our findings at both national and international meetings. You will not be 
identified by name in any reports we write. 
 
Who is organizing and funding the research? 
The research will be carry out by the principal investigator, postgraduate student 
Mannaa Aldowsari, under the supervision of Prof. M.S. Duggal, Dr Jinous F 
Tahmassebi and Dr Marina Malinowski.  The study is being sponsored by 
University of Leeds  
Contact for further information: If you would like any further information at all, 
either before or during the study, please do not hesitate to contact any one of us: 
  
Name    Telephone    e-mail 
Mannaa Aldowsari                 07843925822                                        dnmka@leeds.ac.uk 
Professor Monty Duggal        ( 0113)3436177                                     M.S.Duggal@leeds.ac.uk  
Dr Jinous F Tahmassebi          (0113)3433955                                     
J.Tahmassebi@leeds.ac.uk                                                










                                                    
DREC No: 
Patient Identification Number: 
 
 
CONSENT FORM   
 
Title of Project: The use of caries preventive agents alone and in regimen for prevention 




Name of Researcher: Mannaa Aldowsari  
 
       Please initial box 
 
 
1. I confirm that I have read and understand the information sheet dated 5th September 2016 
(version 4) for the above study. I have had the opportunity to consider the  
    information, ask questions and have had these answered satisfactorily.    
 
2. I understand that my participation is voluntary and that I am free to withdraw   
    at any time, without giving any reason, without my medical care or legal rights  
    being affected.                                                                                                                   
 
3. I understand that relevant sections of any of my medical notes and data collected  
   during the study may be looked at by clinicians involved in the study,  from regulatory   
   authorities or from the NHS Trust where it is relevant to my taking part in research.  
 




________________________ ________________ ____________________ 
Name of Volunteer  Date Signature 
 
 
_________________________ ________________ ____________________ 






When completed, 1 for volunteer; 1 for researcher site file; 





Appendix 6: Case record form (CRF). 
 






Participant Initials: __ __ __    Participant DOB: __ __ / __ __/ __ __ __ __ 
                               
Screening No.: ___ ___ ___ 
  
Participant ID No.: __ __ __                                 
 




                                             Case Record Form 
 
THE USE OF CARIES PREVENTIVE AGENTS ALONE AND IN REGIMENS 
FOR PREVENTION OF ENAMEL DEMINERLISATION UNDER CARIOGENIC 
CHALLENGE IN SITU. 
 
 
Ethics Committee Ref No: 140616/MA/205  
 
Academic Supervisors                       Research Investigator  
 Dr Jinous F Tahmassebi    
(Paediatric Dentistry department) 
Professor Monty Duggal 
Mannaa Aldowsari 
 




(Paediatric Dentistry department) 
Dr Marina Malinowski 
(Paediatric Dentistry department) 
 
Screening Visit                          
 
 
 Medical History     
                 
 
Any medical conditions to report?      ☐ Yes              ☐ No 
 
 
List any relevant previous and current medical conditions (including allergies) and 





















































*Note that if any treatment(s) is/are currently being taken for any of the above conditions this 
(these) must be recorded in the following table (Current/Concomitant medication) 
 
















    
 
 
    
 
 
    
 
 
    
 
Participant Information Sheet Version No. __ 
Dated: __ __/__ __/__ __ __ __ 
 
 
       Yes ☐              No ☐ 
Date given __ __/__ __/__ __ __ __ 
 
 
Participant Consent Form Version No. __ Dated: 
__ __/__ __/__ __ __ __ 
 
 
      Yes ☐              No ☐ 
Date given __ __/__ __/__ __ __ __ 
 







Researcher’s Signature:…………………..      Date   __ __/__ __/__ __ __ __ 
 
 
SCREENING VISIT     
                
Inclusion Criteria Checklist* 
 
1. Age ≥ 18 years < 65 
 
Yes    No 
 
☐    ☐ 
2. General Health 
 
 No relevant medical history and under no medication that 
is known to affect the oral cavity, the oral flora status and 
salivary flow rate 
 









3. Dental examination 
 
i. Presence of at least 18 natural teeth 
 
ii. Free from visual signs of untreated caries or 
periodontal disease or any other adverse dental oral 




iii. Unstimulated salivary flow rate ≥ 0.2 ml/min 












☐          ☐ 
4. Compliance 
 
 Fully understands and is willing, able and likely to 







 Demonstrates understanding of the study and 
willingness to participate as evidenced by voluntary 








*Note: If any of the above questions are answered “No”, the participant should 
be discontinued from the study as a “Screen failure” on the study conclusion 
page. 
 
Researcher’s Signature:…………………..   Date   __ __ / __ __/ __ __ __ __ 
 
 
SCREENING VISIT                    
Exclusion Criteria Checklist* 
 
1. Age: < 18 years > 65 
Yes    No 
☐         ☐ 
2. General Health: 
 Current or recurrent disease that could affect the oral 
cavity or interfere with the dental examination and/or 
wearing of oral appliance 
 Severe psychiatric, physical and medical disorders 
requiring treatment or making the participant unlikely to 
give informed consent or to cope with the procedures 
required by the study protocol 




☐         ☐ 
 
 
☐         ☐ 
  
 
☐         ☐ 
 
3. Medication 
 Medication that is known to affect the oral cavity, oral flora 
status and salivary flow rate 
 Antimicrobial therapy within 14 days prior to screening or 
during the study 
 Antibiotic treatment within 28 days prior to screening or 
during the study 
 
☐         ☐ 
 
☐         ☐ 
 
☐         ☐ 
 4.Dental details 
 Dental disease that require immediate treatment 
 Oral surgery or extraction 6 weeks prior to screening or 
during the study 
 Wearing of prostheses or orthodontic appliances that 
could affect the study procedures  
 Unstimulated salivary flow rate < 0.2ml/min 
 Stimulated salivary flow rate < 0.8 ml/min 
 
 
☐         ☐ 
☐         ☐ 
☐         ☐ 
 
☐         ☐ 
 
☐         ☐ 
5.Clinical trials 
 Participation in another clinical study or receipt of an 
investigational drug within 30 days of the screening and 
during the study 
 
 





 Known or suspected intolerance/ hypersensitivity to 
study materials or ingredients that will be used in the 
study 
 
☐         ☐ 
 
☐         ☐ 
*Note: If any of the above questions are answered “Yes”, the participant should 
be discontinued from the study as a “Screen failure” on the study conclusion 
page. 
 




SCREENING VISIT             Time of Dental Examination.: __ __: __ __ 
 




















No. of teeth: 
 





 Salivary Flow Rate 
 
Unstimulated:  _. _ _ ml/min           (Must be ≥ 0.2 ml/min) 






















Researcher’s Signature:…………………..   Date   __ __ / __ __/ __ __ __ __ 
 
In the investigator’s opinion, on the basis of the screening 
assessments and inclusion and exclusion criteria, is the 
participant eligible to participate in the next part of the study? 
 
 






Screening Visit Checklist 
 
 
Personal Data sheet completed 
 
 
      Yes ☐              No ☐ 
 
Medical History checked 
 
 
 Yes ☐              No ☐ 
 
Dental Examination completed 
 
 
Yes ☐              No ☐ 
 
Inclusion Criteria Sheet completed 
 
 
Yes ☐              No ☐ 
 
Exclusion Criteria Sheet completed 
 
 
      Yes ☐              No ☐ 
 
Eligibility Sheet completed 
 
 
      Yes ☐              No ☐ 
 
 














 Lower alginate impression  
 
            ☐ 
 
 Any problems?                    YES   ☐          NO ☐ 
 
If Yes, give details……………………………………………….. 
      …………………………………………………………………. 
.………………………………………………………………… 
 
Researcher’s Signature Date 















 Any problems?                    YES   ☐         NO ☐ 
 





Have there been any changes to the 
participant’s medication record since 
the last visit? 
 (*If yes please complete the 
Concomitant Medication page ) 
 
Have there been any changes to the 
inclusion/exclusion criteria since the 
last visit? 
 
Is the participant still eligible to 
continue in the study?   
 
 











YES ☐  NO ☐ 
 Instructions & restrictions 
explained 
 
YES ☐  NO ☐ 
 




YES  ☐   NO  ☐ 
 





Researcher’s Signature Date 
………………….. 
 
__ __/__ __/__ __ __ __ 
   
Third Visit 
 
Date__ __ / __ __/ __ __ __ __ 
 




 Any problems?                       YES    ☐      NO   ☐ 








Have there been any changes 
to the participant’s medication 
record since the last visit? 
 
 (*If yes please complete the 
Concomitant Medication page 
) 
 
Have there been any changes 
to the inclusion/exclusion 
criteria since the last visit? 
 
Is the participant still eligible to 















YES ☐  NO ☐ 




















 Fitting of appliance 
 
 
  ☐ 
  
 Any problems?                      YES    ☐         NO   ☐ 
 








Have there been any changes 
to the participant’s medication 
record since the last visit? 
 
 (*If yes please complete the 
Concomitant Medication page 
) 
 
Have there been any changes 
to the inclusion/exclusion 
criteria since the last visit? 
 
Is the participant still eligible to 















        YES ☐  NO ☐ 
 









YES    ☐        NO   ☐ 
__ __ /__ __/__ __ __ __ 






















 Any problems?                       YES     ☐       NO   ☐ 
 









Have there been any changes 
to the participant’s medication 
record since the last visit? 
 
 (*If yes please complete the 
Concomitant Medication page 
) 
 
Have there been any changes 
to the inclusion/exclusion 
criteria since the last visit? 
 
Is the participant still eligible to 
continue in the study 
 




































 Fitting of appliance 
 
 
  ☐ 
  
 Any problems?                      YES    ☐         NO   ☐ 
 







Have there been any changes to the 
participant’s medication record since 
the last visit? 
 
 (*If yes please complete the 
Concomitant Medication page ) 
 
Have there been any changes to the 
inclusion/exclusion criteria since the 
last visit? 
 
Is the participant still eligible to 
continue in the study 
 
 










   YES ☐  NO ☐ 
 









 YES    ☐        NO   ☐ 
 
__ __ /__ __/__ __ __ __ 


















Date__ __ / __ __/ __ __ __ __ 
 





 Any problems?                       YES     ☐       NO   ☐ 
 








Have there been any changes 
to the participant’s medication 
record since the last visit? 
 
 (*If yes please complete the 
Concomitant Medication page 
) 
 
Have there been any changes 
to the inclusion/exclusion 
criteria since the last visit? 
 
Is the participant still eligible to 
continue in the study 
 
 






        



























 Fitting of appliance 
 
 
  ☐ 
  
 Any problems?                      YES    ☐         NO   ☐ 
 







Have there been any changes to the 
participant’s medication record since 
the last visit? 
 
 (*If yes please complete the 
Concomitant Medication page ) 
 
Have there been any changes to the 
inclusion/exclusion criteria since the 
last visit? 
 
Is the participant still eligible to 
continue in the study 
 
 






        




   YES ☐  NO ☐ 
 









 YES    ☐        NO   ☐ 
 
__ __ /__ __/__ __ __ __ 



























Ninth  Visit 
 










 Any problems?                       YES     ☐       NO   ☐ 
 





Have there been any changes to the 
participant’s medication record since 
the last visit? 
 
 (*If yes please complete the 
Concomitant Medication page ) 
 
Have there been any changes to the 












       YES ☐   NO ☐ 
 
 
 Application of topical fluoride 
 
 

























Has the participant required any modification to their appliance? 
*If yes, please specify in the comments’ box below. 
 Yes*   No 
 
Comments 




















































Did the participant complete the entire study?      Yes ☐           No* ☐ 
 
If “ Yes”, Date completed: _ _/ _ _/ _ _ _ _ 
 
If “No” is checked, please complete the following (Please check as an appropriate): 
 
Screen Failure                                ☐ 
 
 
Adverse Event                                ☐ 
 
 
Lost to follow-up                            ☐ 
 
 





















I confirm that I have reviewed all the data collected in this Case Report Form and take 











Appendix 7: Dipping diary and instruction sheet for non- 
regimen groups. 
 
THE USE OF CARIES PREVENTIVE AGENTS ALONE AND IN REGIMEN FOR 
PREVENTION OF ENAMEL DEMINERALISATION UNDER CARIOGENIC 




BRIEF INFORMATION FOR COMPLETION OF THE 
FOLLOWING DIARY CARD 
 
 
 Brushing should occurs initially in the morning and before bed (Please 
remove appliance when brushing- brushing is for 2 mins. 
 
 Guidelines for the frequency of dipping in a sugar solution and in a slurry of 
toothpaste: 
 
Each dipping in sugar solution = 2 minutes and the time should be recorded 
in the diary log. 
 
Dipping in sugar solution is 5 times per day. The interval between dipping in 
sugar solution is not less than 1 hour. 
 
Dipping in slurry toothpaste is 2 times per day (morning and evening) 
 for 2 minutes. 
 
Example of completed diary card: 
 







( 2 min) 


















09/11/16 yes 8:00am 9:00am 12:00pm 3:00pm 6:00pm 8:oopm 9:00pm yes 
 
 







Participant Initials: __ __ __  
Screening No.: __ __ __ 
Leg no: _ _  
Randomisation No: __ __ __ 
 
Dipping Diary Sheet: 
Fluoride –free toothpaste (washout period) start date:                       _ _ / _ _ / _ _ _ _ 
Dental device using start date                                                                  _ _ / _ _ / _ _ _ _                                  
Dental device dipping start date                                                              _ _ / _ _ / _ _ _ _                                  
 







( 2 min) 


















          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          
          




Appendix 8: Dipping diary and instruction sheet for the 
regimen groups. 
 
THE USE OF CARIES PREVENTIVE AGENTS ALONE AND IN REGIMEN FOR 
PREVENTION OF ENAMEL DEMINERALISATION UNDER CARIOGENIC 
CHALLENGE IN SITU.  
Regimen Phase 
 
BRIEF INFORMATION FOR COMPLETION OF THE 
FOLLOWING DIARY CARD 
 Brushing should occurs initially in the morning and before bed (Please 
remove appliance when brushing- brushing is for 2 mins. 
 
 Guidelines for the frequency of dipping in a sugar solution and in a slurry of 
toothpaste: 
 
Each dipping in sugar solution = 2 minutes and the time should be recorded 
in the diary log. 
 
Dipping in sugar solution is 5 times per day. The interval between dipping in 
sugar solution is not less than 1 hour. 
 
Dipping in slurry toothpaste is 2 times per day (morning and evening) 
 for 2 minutes. 
 
 Apply a pea-sized amount of tooth mousse plus (MI Paste) to your teeth's 
surface using your finger and Leave undisturbed for 3 minutes. (Please do 
not remove the appliance while applying the MI paste). 
 
Example of completed diary card: 
 







( 2 min) 






















09/11/16 yes 8:00am 9:00am 12:00pm 3:00pm 6:00pm 8:oopm 9:00pm yes yes 
 




Participant Initials: __ __ __  
Screening No.: __ __ __ 
Arm no: _ _  
Randomisation No: __ __ __ 
 
Dipping Diary Sheet: 
Fluoride –free toothpaste (washout period) start date:                       _ _ / _ _ / _ _ _ _ 
Dental device using start date                                                                  _ _ / _ _ / _ _ _ 
_                                  
Dental device dipping start date                                                              _ _ / _ _ / _ _ _ 

















Dipping in sugar 
solution for 2 min 
Evenin






























           
           
           




           
           
           
           
           
           
           
           
           
           
Thank you for your cooperation 
 
